Quarterlytics / Basic Materials / Other Precious Metals / Almirall

Almirall

alm · LSE Basic Materials
Claim this profile
Ticker alm
Exchange LSE
Sector Basic Materials
Industry Other Precious Metals
Employees 201-500
← All annual reports
FY2022 Annual Report · Almirall
Sign in to download
Loading PDF…
ALLIED MINDS PLC 

ANNUAL REPORT AND ACCOUNTS 
For the year ended 31 December 2022 

 
 
 
 
 
 
 
 
 
 
 
Contents 

Strategic Report 
Highlights 
Company Overview 
Portfolio Review and Developments 
Key Performance Indicators 
Financial Review 
Risk Management 

Management and Governance 

Directors’ Report 

Financial Statements 

Independent Auditor’s Report 
Consolidated Financial Statements 
Notes to the Consolidated Financial Statements 
Company Balance Sheet  
Notes to the Company Financial Statements 

Company Information 

Page 
no. 

3 
5 
7 
12 
13 
16 

23 

29 
34 
38 
85 
88 

92 

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STRATEGIC REPORT 

Highlights 

Investment & Financial Highlights 

(cid:120)  $64.0 million invested in portfolio companies, of which $63.0 million was raised from third-party 

investment. 

(cid:120)  Cash and cash equivalents at 31 December 2022: $7.8 million (FY21: $9.7 million), of which $7.8 
million is held within Allied Minds plc, Allied Minds LLC and Allied Minds Securities Corp (FY21: 
$9.0 million). 

(cid:120)  Revenues of $1.6 million (2021: $1.5 million) mainly from non-recurring engineering (NRE) and 
service  contracts  within  BridgeComm,  reflecting  the  early-stage  nature  of  our  portfolio 
companies. 

Selected Portfolio Company Highlights –  

(cid:120)  BridgeComm (“BCI”) (equity accounted investment): 

o  Closed a $2 million Series B-2 financing on September 9 that provides a new ownership 
structure that will enable BridgeComm (‘BCI’) to qualify as a US company and bid for US 
Space Development Agency business as a prime contractor. 

o  The revised structure reduced Allied Minds’ fully-diluted ownership to 39.77%, leading to 
the company being deconsolidated from the group accounts as of September 9. The new 
ownership structure sets up BCI to potentially deliver substantial upside return.   

o  BCI’s focus is now on productizing and commercialising its technology – which will require 

more time and capital 

o  BCI  has  identified  a  pipeline  of  revenue  opportunities  worth  $1.7bn.  These  include 
commercial inter-satellite connections, terrestrial telecoms connections and US defense 
opportunities.  

o  Allied  Minds  and  Aeroequity  Industrial  Partners  (“AEI”)  have  each  committed  an 
additional $1m of capital to BCI to finance its activities during the capital raise period. 
o  Following the period end on March 24, BCI secured a $1.5 million convertible note from 

a strategic investor.  

(cid:120)  Federated Wireless (“Federated”) (equity accounted investment): 

o  Federated closed a $72 million in Series D financing, giving the business an increased post-

money valuation of $302 million. 

o  Allied Minds’ bridge financing fully converted following the completion of the Series D 
funding  rounds.  As  a  result,  Allied  Minds'  fully(cid:486)diluted  ownership  of  the  issued  share 
capital of Federated Wireless stands at 23.96%. 

o  Federated  Wireless  deployed  its  private  wireless  and  shared  spectrum  technology  to 

deliver industry-first solutions and use cases.  

3 

 
 
 
 
 
 
(cid:120)  OcuTerra (ordinary and preference share holding investment held at fair value): 

o  OcuTerra  commenced  the  Phase  2  trial  of  its  non-invasive  eyedrops  (OTT166),  an 
important  milestone  in  its  efforts  to  develop  the  first,  topical  eye  drop  treatment  for 
diabetic retinopathy.   

o  Enrolment  has  been  held back  by  an  adverse  environment  for  clinical  trials  in the  US. 
However,  the  company  targets  completion  of  enrolment  by  the  end  of  Q3  2023  with 
topline data read out in the first half of 2024.  

o  OcuTerra continued to strengthen its managerial and clinical team with the 

appointment of eye care industry veteran, Majid Andersi, MD, as Vice President of 
Clinical and Medical Affairs.   

o  OcuTerra agreed a $14 million extension of its Series B funding on December 16 that is 

expected to close in Q2 2023.  

(cid:120)  Orbital Sidekick (“OSK”) (preference share holding investment held at fair value): 

o  Orbital Sidekick raised a $11 million extension of its Series A round. 
o  Signed a contract with one of the largest pipeline operators in North America - Energy 
Transfer - to deliver recurring monitoring services from its satellites through 2023. 
o  Entered an agreement with In-Q-Tel (“IQT”) to deliver timely and relevant insights to IQT’s 

o 

government partners.  
In March 2023 OSK won a contract from the National Reconaissance Office (“NRO”)  for 
its  latest  focus  area  study  of  commercial  space-based  hyperspectral  imaging  (HSI) 
capabilities.  

o  OSK launched two satellites, GHOSt 1 and 2 on 15 April 2023 and launched GHOSt 3 on 8 
June 2023. They are currently in the process of being commissioned which is expected to 
take approximately 2 months.  

(cid:120)  Touch Bistro (ordinary share holding investment held at fair value) 

o  On  28  March  2022,  Allied  Minds  announced  that  it  had  completed  the  disposal  of  its 
residual shareholding in Touch Bistro for CAD$5.5m ($4.4m USD) in line with its strategy 
of monetising its investment portfolio.  

o  On 23 August 2022, the remainder of the shares held in escrow were released, resulting 

in cash received of CAD$0.53m. 

(cid:120)  Concirrus (preferred share holding investment held at fair value) 

o 

In  Q4  2022,  Concirrus  initiated  a  sale  process  that  completed  in  Q1  2023.  The 
consideration did not generate a return to common stock. This position was written down 
to zero at 31 December 2022.  

Corporate Developments  

(cid:120)  Reshaped the board following the departure of Harry Rein (Non-Executive Chairman) and Mark 
Lerdal (Non-Executive Director); Bruce Failing appointed Interim Non-executive Chairman while 
Sam Dobbyn and Juan Morera joined as Non-Executive Directors.  

(cid:120)  On 30 November 2022 the Company announced that the listing of ordinary shares on the Official 
List of the Financial Conduct Authority and admission to trading on the Main Market for listed 
securities of the London Stock Exchange was cancelled. 

4 

 
 
 
 
 
 
(cid:120) 

In line with the Board’s strategy to reduce its expense base and preserve cash the Company has 
outsourced  its finance  and  administration  function. As  a  result of  actions  taken  to  reduce  the 
expense base, including the delisting of the Company, the Board expects run rate expenses to be 
less than $2 million in future years.  

(cid:120)  On 17 November 2022, the Company announced the launch of a share repurchase programme. 
This was required to meet the Company’s contractual obligations with staff and directors without 
diluting shareholders. A total of 2,176,229 shares were purchased for a total cost of $0.2 million. 

Company Overview 

Overview  

Allied Minds is an IP commercialisation company primarily focused on early-stage company development 
within the technology sector.   

We  have  historically  invested  in  companies  at  an  early  stage,  including  seed  investments  to  build 
companies  based  on  a  technical  breakthrough  or  invention.  As  such,  our  investments  have  significant 
upside potential, but also carry significant risk inherent in the early-stage model.   

There  are  currently  four  portfolio  investments  based  upon  a  broad  range  of  underlying  innovative 
technologies ranging from wireless connectivity to space-based imagery and analytics.   

The Group remains focused to execute its plan to maximise the value of its portfolio company interests 
and deliver well-timed, risk-adjusted returns for its shareholders. 

Model  

As a manager of a technology-focused portfolio in which we hold significant ownership positions, we seek 
to provide hands-on support over the life of our companies to support their growth, focusing on enabling 
and  driving  commercialisation,  supporting  follow-on  investment  rounds,  and  positioning  for  superior 
monetisation opportunities.   

We seek to play an active role in developing the strategic direction of our portfolio companies and driving 
ongoing planning and assessment. Our Non-Executive Directors serve on the boards of directors of our 
portfolio companies, working with them to develop and implement strategic, operating and funding plans. 
Following the recent changes to the board of Allied Minds, Bruce Failing currently sits on the board of 
Federated Wireless. Sam Dobbyn has been appointed director of Federated Wireless and Orbital Sidekick. 
Juan Morera sits on the boards of both BridgeComm and OcuTerra.  

We  evaluate  on  an  on-going  basis  the  progress  and  potential  of  each  of  the  portfolio  company’s 
businesses  and  make  strategic  and  funding  decisions  based  on  the  regular  review  of  operational  and 
financial  performance  and  the  achievement  of  key  milestones.  Together  with  our  management,  the 
respective portfolio company boards of directors define the critical milestones, or inflection points, for 
each portfolio company and measure tangible progress towards commercialisation and the key factors 
for a successful monetisation event.   

Where appropriate, we seek to include partners who validate the market opportunity and can provide 
support  and/or  commercial  commitments  to  accelerate,  expand  and/or  de-risk  the  path  to 
commercialisation. Co-investors in later rounds include financial, strategic and commercial partners.  

5 

 
 
 
 
Strategy 

Allied  Minds  is  focused  on  supporting  its  existing  portfolio  companies  and  maximising  monetisation 
opportunities  for  portfolio  company  interests.  In  March  2022,  the  Company  announced  that  it  was 
undertaking a formal strategic review, aimed at creating and / or realising shareholder value. As part of 
this  strategic  review,  the  Board  has  sought  to  ensure  that  the  Company  is  being  managed  in  as  cost-
efficient  manner  as  possible.  In  conducting  this  review,  the  Board  determined  that  the  costs  of 
maintaining a premium listing on the Official List and the Main Market of the London Stock Exchange was 
prohibitively  high  relative  to  Allied  Minds'  current  size  and  on  30  November  2022  the  Company 
announced that the listing of ordinary shares on the Official List of the Financial Conduct Authority and 
admission to trading on the Main Market for listed securities of the London Stock Exchange was cancelled. 

Outlook 

There  was  good  technical  and  commercial  progress  from  certain  portfolio  companies  during  the  year 
ended  31  December 2022,  including  a successful funding round  at Federated Wireless  at  an  improved 
valuation. The milestones achieved demonstrate the innovative nature of the products and services within 
the portfolio, which address a range of large potential markets and provide a strong platform for creating 
shareholder value.  

The Board of Allied Minds continually assesses its portfolio of investments and takes informed decisions 
supported by up-to-date information. As part of this process, a member of the Allied Minds board sits on 
the boards of all our material investments, and this remains the case following the recent departure and 
appointment of certain directors at Allied Minds.  

Although  Allied  Minds’ portfolio  companies are  mostly  at a  relatively  early stage  in  their  lifecycle, the 
Board remains positive about their prospects upon exit if the portfolio companies continue to meet their 
planned technical and commercial goals. 

Management  continuously  monitors  and  reviews  international  risks  such  as  economic  headwinds, 
including  inflationary  pressures,  interest  rates  and  component  price  increases,  as  well  as  changes  in 
political and regulatory requirements. The failure of Silicon Valley Bank (“SVB”), and other US regional 
banks, in March 2023 had no material impact on either the Group, or its portfolio companies, due to the 
actions taken by the FDIC to protect depositors. However, the failure of SVB, as well as recent increases 
in US interest rates, has increased economic uncertainty and made for a more challenging fund raising 
environment.  As  a  result,  the  Directors  are  focusing  on  ensuring  that  the  Group  and  its  portfolio 
companies  appropriately  manage  their  cash  resources.  The  Directors  have  also  put  in  measures  to 
mitigate  against the  risks  to the  business  such  as  the  wider  cost  of  living  challenges,  re-emergence of 
COVID-19 and uncertainty caused by the situation in Ukraine. Furthermore, the directors have determined  
the dynamics will not affect Allied Minds from a going concern perspective.   

Portfolio Company Valuation  

Of the Company’s four active portfolio companies, the Company holds a significant influencing minority 
stake in three of these companies and non-significant position in OcuTerra.  In each case, where Allied 
Minds holds a significant minority stake, it is able to exercise its influence over the portfolio company by 
virtue of its large, albeit minority, ownership stake in the portfolio company and its representation on the 
board of directors. The investment in preferred stock in these portfolio companies is accounted for under 

6 

 
 
 
IFRS  9  and  is  classified  by the  Company  as  an  investment  at  fair value  in  the  Company’s  consolidated 
financial statements. Due  to the  equity-like characteristics of the Company’s common stockholdings in 
both  BridgeComm  and  Federated  Wireless,  these  investments  are  accounted  for  under  IAS  28  and  is 
classified  by the Company  as investments in  associates.  Accordingly,  since Allied  Minds  has  significant 
influence over these entities through the voting rights held, it gives access to the returns associated with 
an ownership interest in these associates. For Ordinary stock holdings, where the group does not have 
significant  influence,  these  investments  are  held  at  fair  value  in  the  Company’s  consolidated  financial 
statements. 

Allied Minds provides qualitative and quantitative disclosure in relation to the commercial and financial 
progress  of  its  portfolio  companies,  and  directional  commentary  on  valuation.  In  addition,  where 
commercially possible, Allied Minds provides, for each portfolio company: (i) the date of the last equity 
funding round, (ii) the post-money valuation of such round, (iii) the named key co-investors in such round, 
and (iv) the Company’s issued and outstanding ownership (when provided by the portfolio company), and 
fully-diluted ownership, of such portfolio company.   

This  information  is  set  forth  in  the  Portfolio  Review  and  Developments  section  below. The ownership 
interests are as of 31 December 2022. The fully-diluted percentages take into account outstanding stock 
options granted to employees, directors and advisors, current stock options available for grant pursuant 
to the company’s stock option plan, and outstanding warrants to purchase common and preferred stock.  

The post-money valuations disclosed for each entity below do not represent IFRS 13 fair values but rather, 
are based on the pre-money valuation set by the investors in the latest financing round plus the  total 
money raised in that round.   

There can be no guarantee that the aforementioned post-money valuations of the portfolio companies 
will be considered to be correct in light of the future performance of the various companies, or that the 
Company would be able to realise proceeds in the amount of such valuations, or at all, in the event of a 
sale by it of any of its portfolio companies or its ownership interest in such portfolio companies.   

Portfolio Review and Developments  

---------- 

1)  BridgeComm Inc. (BCI) (equity accounted investment) 

BCI is developing high-speed optical wireless communications to provide fast, secure, enterprise-grade 
broadband service for space, terrestrial and 5G connectivity. It has created in the lab, and demonstrated 
over  100  meters,  high-capacity,  secure,  one-to-many  optical  communications  capabilities  that  may 
represent  a  paradigm  shift  in  the  low  earth  orbiting  satellite  constellations  communications  and 
battlefield communications. This technology offers a potential low-cost alternative to laying fiber optic 
cable in underserved and hard to reach cellular geographies.  

As previously announced, in order to ensure BCI can bid for US Space Development Agency business as a 
prime contractor, BCI could not be majority owned by a foreign company. Allied Minds therefore agreed 
to  a  new  ownership  structure  with  Aeroequity  Industrial  Partners  (“AEI”).  In  order  to  implement  this 
structure, $2 million of existing Allied Minds debt with BCI was not converted. Allied Minds’ fully diluted 
ownership prior to the transaction was 62.92%. 

7 

 
 
Further, BCI closed a $2 million Series B-2 financing in which both AEI and Allied Minds invested $1 million 
each (inclusive of previous bridge loans), in order for the company to continue operations whilst it seeks 
to raise further funds from interested investors. The result is Allied Minds' ownership being 39.77% on a 
fully diluted basis. 

In addition to the ownership percentage held by Allied minds being reduced below 50% enabling BCI to 
qualify as a company with US ownership, BCI will also benefit from the significant US government contacts 
and aerospace knowledge that AEI brings to the company.  Also, Boeing, a significant BCI customer is an 
investor through Space X in AEI. Allied Minds believes that taking an economic write-down now sets the 
company up for future success and the potential for a significant total return. 

BridgeComm now needs to productise and commercialise its technology. BCI will seek to raise $10m from 
interested  investors and  is  in  the  later  stages of bidding on two  contracts. Either of those  contracts is 
capable of providing funding of up to $30m of the required $40m through non-recurring engineering fees 
paid for by the customer. In the meantime, Allied Minds and AEI have each committed an additional $1m 
of capital to BCI to finance its activities during the capital raise period. 

While the process of going from the lab to a commercialised product is uncertain, the economic upside 
for BCI and Allied Minds could be substantial and as such we are optimistic for BCI's success.  

Holdings and valuation: 

(cid:120)  Date of Last Funding Round: September 2022 
(cid:120)  Post-Money Valuation: $11.5 million 
(cid:120)  Co-Investors: AE Industrial HorizonX Venture Fund I, LP 
(cid:120)  Allied Minds’ Issued and Outstanding Ownership: 49.55%. As a result of its smaller equity position, 
Allied  Minds  no  longer  controls  BCI  but  continues  to  have  significant  influence  and  board 
representation. 

(cid:120)  Allied Minds’ Fully-Diluted Ownership: 39.77% 

2)  Federated  Wireless Inc.  (Federated)  (equity  accounted  investment  and  preferred  share  investment 

held at fair value) 

Founded in 2012, Federated is the market leader in Citizen Band Radio Service (CBRS) shared spectrum. 
Shared spectrum,  also  known  as CBRS, is  an  innovative technology that delivers the  best  attributes  of 
traditional wireless and Wi-Fi, with lower fixed cost, higher quality, and greater efficiency and scale.  

As the first to market with a Spectrum Access System (“SAS”), Federated Wireless is the nationwide leader 
in the United States in enabling, commercialising, and driving adoption of shared spectrum. With more 
than  350  customers  and  over  90,000  connected  devices  across the  United  States and  territories,  the 
company serves a customer base  spanning defense, government, manufacturing, telecommunications, 
utilities, real estate, and education, with a wide range of use cases ranging from network densification 
and mobile offload to private wireless and industrial IoT. Noteworthy customers include Charter, Comcast, 
Verizon, the US Department of Defense and Carnegie Mellon University.  

In H1 2022, Federated Wireless raised $72 million through a two-stage Series D funding to fuel growth in 
5G private wireless and other strategic focuses. An affiliate of Cerberus Capital Management, L.P. led the 

8 

 
 
 
round, with affiliates of Fortress Investment Group, Giantleap Capital, and LightShed Ventures added as 
new  investors  with  existing  investors  Allied  Minds  and  GIC,  Singapore’s  sovereign  wealth  fund,  also 
participating. The Series D funding was completed at a pre-new-money valuation of $230 million, resulting 
in a post-new-money valuation of $302 million, up from the Series C post-money valuation of $215 million 
published in the Allied Minds’ Annual Report and Accounts for the year ended 31 December 2020. Allied 
Minds fully diluted ownership following this transaction was 23.96%, reduced from 36.61%. 

Federated Wireless entered a joint industry collaboration with Blue White Robotics and Intel to automate 
agricultural  solutions.  This  first-of-a-kind  implementation  greatly  reduces  the  barriers  for  growers  to 
adopt  automation  that  can  improve  business  outcomes  while  addressing  labour  shortages.  Partnering 
with a California winery, the collaborators adapted existing farm equipment to perform autonomous tasks 
and connected the fleet over a private wireless network. Federated Wireless deployed a private wireless 
network in less than three days which covered the vineyard’s 2.1 square miles. The network leveraged 
Intel Smart Edge and an edge server with a six-core Intel Xeon D-1528 processor to successfully connect 
a mix of autonomous tractors, sensors and other data points. 

Federated  Wireless  also  partnered  with  leading  IoT  distributor  CalChip  Connect  to  deliver  end-to-end 
solutions  and  services  to  power  plug-and-play  decentralized  5G  networks.  The  strategic  collaboration 
provides an end-to-end service for consumers and small enterprises to rapidly implement a plug-and-play 
decentralized 5G network solution that can be setup in as little as 20 minutes. 

The  Board of Federated expects continued growth into 2023. These expectations come with the usual 
risks commensurate with high growth businesses of this nature. 

Holdings and valuation: 

(cid:120)  Date of Last Funding Round: May 2022  
(cid:120)  Post-Money Valuation: $302 million 
(cid:120)  Co-Investors: Cerberus Capital Management LLP and GIC (Singapore’s sovereign wealth fund) 
(cid:120)  Allied Minds’ Issued and Outstanding Ownership: 32.79% 
(cid:120)  Allied Minds’ Fully-Diluted Ownership: 23.96% 

3)  OcuTerra Therapeutics, Inc. (ordinary and preference share holding) 

OcuTerra is a clinical stage ophthalmology company developing innovative small molecule drugs for non-
invasive  use  in  treating  ophthalmologic  diseases  that  are  currently  treated  in  the  early  stages  with  a 
“watch and wait” protocol.  

Following the completion of a $35 million Series B funding in November 2021, the company commenced 
a Phase 2 trial in Q3 2022 of its non-invasive eyedrops (OTT166) for use in early active management of 
Diabetic Retinopathy. The trial is studying the treatment of moderate to severe non-proliferative and mild 
proliferative Diabetic Retinopathy, a disease that results in loss of vision for diabetic patients. 

In  August  2022,  OcuTerra  announced  the  first  patient  had  been  dosed  in  its  Phase  2  DR:EAM 
(Diabetic Retinopathy: Early Active Management) clinical trial. OTT166 is a novel small molecule selective 
integrin  inhibitor  that  is  designed  with  purpose  engineering  to  have  the  required  physiochemical 

9 

 
 
characteristics to be able to reach the retina from eye drop application.  

In April 2023, following the period end, the company had enrolled half of its required number of patients. 
Full enrollment is expected by the end of Q3 2023, with topline data available in H1 2024.  

OTT166 has been specifically designed to be administered as an eye drop by the patient at home before 
diabetic retinopathy has advanced to a vision-threatening complication, such as diabetic macular edema. 
By potentially enabling earlier non-invasive treatment, OcuTerra’s goal is to prevent progression, thereby 
delaying or completely eliminating the need for intravitreal injections and/or destructive laser procedures. 

Phase 1b clinical trials of OTT166 eye drops in patients with diabetic retinopathy and wet AMD previously 
demonstrated safety,  tolerability and clear clinical evidence of biological activity. If the Phase 2 trial is 
successful, the next step would be a Phase 3 trial involvin6g more patients and if successful in meeting 
the clinical end points application to the FDA for approval.   

In  line  with  the  company’s  previously  stated  strategy  to  build  out  its  managerial  and  clinical  team, 
OcuTerra  appointed  eye  care  industry  veteran  Majid  Anderesi,  MD,  as  Vice  President  of  Clinical  and 
Medical Affairs in April 2022.  

Allied Minds is the largest shareholder in OcuTerra.  

OcuTerra agreed a $14 million extension of the Series B funding in December 2022, which is expected to 
complete in Q2 2023.  

Holdings and valuation: 

(cid:120)  Date of Last Funding Round: November 2021  
(cid:120)  Valuation: $51.3 million 
(cid:120)  Co-Investors: Various third parties 
(cid:120)  Allied Minds’ Issued and Outstanding Ownership: 17.06% 
(cid:120)  Allied Minds’ Fully-Diluted Ownership: 11.20% 

4)  Orbital Sidekick Inc. (OSK) (preference share holding) 

OSK has developed a proprietary analytics platform based upon its hyperspectral technology that allows 
it to take a proprietary “chemical fingerprint” from space.  Initially, OSK is addressing the very current and 
large concerns about the environment by focusing on potential energy pipeline failures. By employing its 
space-based technology, it  is  able to  detect and identify natural  gas, oil leaks and other  failures much 
more rapidly than current monitoring techniques in a more cost-effective way while helping to minimise 
environmental damage.  

In June 2022, the company signed a contract with one of the largest pipeline operators in North America 
—  Energy  Transfer  —  to  deliver  recurring  monitoring  services  from  its  satellites  through  2023.  The 
company also signed a significant work program contract with In-Q-Tel (IQT) to deliver timely and relevant 
insights  to  IQT’s  government  partners  as  part  of  a  rapidly  growing  hybrid  architecture  of  technology 
solutions. In March 2023 OSK won a contract from the National Reconaissance Office (“NRO”)  for its latest 
focus area study of commercial space-based hyperspectral imaging (HSI) capabilities.  The contract aims 
to evaluate and integrate emerging commercial remote sensing capabilities for their ability to support the 

10 

 
 
 
Intelligence Community and Department of Defence mission areas. In addition, the company is developing 
products for the mining and agriculture industries, along with fire fuel and carbon mapping capabilities.  

As  previously  announced,  OSK  was  seeking  to  raise  $40m  which  it  had  hoped  to  close  in  mid-2022. 
Although this was not achieved due to extraneous market events, OSK continued to have investor support 
and a bank facility to allow it to continue operating. The business has strong interest from a number of 
clients wishing to participate in its alpha/beta launch of six satellites in 2023.  

OSK launched two satellites, GHOSt 1 and 2 on 15 April 2023 and launched GHOSt 3 on 8 June 2023. They 
are currently in the process of being commissioned which is expected to take approximately 2 months.  
If commissioning is successful the business should be well placed for additional follow-on funding. 

In January 2023, Orbital Sidekick announced a $12 million extension of its Series A round, which will allow 
the Company to launch additional satellites in Q3 and Q4 2023. 

Holdings and valuation: 

(cid:120)  Date of Last Funding Round: January 2023 
(cid:120)  Post-Money Valuation: $66.6 million  
(cid:120)  Co-Investors: Temasek, Energy Innovation Capital and 11.2 Capital 
(cid:120)  Allied Minds’ Issued and Outstanding Ownership in respect of preference shares: 20.48%  
(cid:120)  Allied Minds’ Fully-Diluted Ownership: 15.76%  

5)  TouchBistro, Inc. (acquirer of TableUp, Inc.) (common shares in TouchBistro) 

On 28 March 2022, Allied Minds announced that it had completed the disposal of its residual shareholding 
in Touch Bistro for $5.5m CAD ($4.4m USD) in line with its strategy of monetising its investment portfolio. 
All of the sale proceeds had been received as of 23 August 2022 when the remaining shares held in escrow 
were released. 

6)  Concirrus Limited (acquirer of Spark Insights, Inc) (preferred share investment) 

On  29  October  2021,  Allied  Minds  Plc  has  disposed  of  its  portfolio  company,  Spark  Insights,  Inc.  to 
Concirrus, a private UK-based insurance technology company in which Concirrus acquired 100% of the 
shares  of  Spark  in  exchange  for  the  issuance  of  Concirrus’  Series  A1  preferred  shares.  Allied  Minds’ 
ownership percentage in Concirrus is 0.87% at 31 December 2022. 

In Q4 2022, Concirrus initiated a sale process that completed on 6 March 2023. The consideration received 
was de minimis. This position was written down to zero at 31 December 2022.  

11 

 
 
 
 
 
Key Performance Indicators 

The  following  Key  Performance  Indicators  (KPIs)  were  selected  to  measure  the  performance  of  the 
Company in 2022.   

1. 

Increase  Company  Non-Executive  Director  (NED)  engagement  at  each  portfolio  company.  We 
have continued to hold NED roles on the board of each of the significant portfolio investments.  
2.  Provide strategic, operational and financing support and assistance to the portfolio companies 
through representation on the board of each portfolio company. We have continued to provide 
this support to each of the portfolio companies throughout the period.   

3.  Critically  evaluate  and  monitor  portfolio  company  progress  with  objective  of  maximising 
shareholder return on investment (ROI). We have critically evaluated the performance and this 
has resulted in the investment portfolio changes in the period.  

4.  Manage HQ cash and expenses to maximise shareholder ROI, HQ expenses in the current year 

were $5.2 million (2021: $5.7 million). 

We  note  that  as  a  result  of  the  strategic  changes  announced  by  the  Board  on  15  January  2021,  the 
portfolio shall be managed by the Board, all of whom are Non-Executive Directors, on a go-forward basis.  
The Board places equal importance on each of the listed KPIs. 

12 

 
 
 
 
Financial Review 

During 2022, $64.0 million was invested into existing portfolio companies. This included $1.0 million 
invested by Allied Minds, with $63.0 million coming from third-party investment, to further accelerate 
the development of the Group’s existing companies.   

Consolidated Statement of Comprehensive Loss 

For the years ended 31 December 

Revenue 
Cost of revenue 
Selling, general and administrative expenses 
Research and development expenses 
Finance loss, net 
Other income/(expense)  
Other comprehensive loss 

 Total comprehensive loss 

 of which attributable to: 
 Equity holders of the parent  
 Non-controlling interests 

2022 
$ '000 

 1,577 
 (571) 
 (6,703) 
 (1,408) 
 (3,865) 
 8,480 
(187) 
(2,677) 

2021 
$ '000 

 1,544 
 (443) 
 (10,569) 
 (2,650) 
 (2,788) 
(1,338) 
(41) 
(16,285) 

 (2,648) 
 (29) 

 (15,575) 
 (710) 

Revenue increased by $0.1 million, to $1.6 million in 2022 (2021: $1.5 million). This increase is primarily 
attributable to revenue from existing and new contracts in 2022 at BridgeComm. Cost of revenue at $0.6 
million  (2021:  $0.4  million) was higher  as a  percentage  of revenue,  when compared  to  the  prior year, 
mainly due to the nature of the revenue being delivered. 

Selling,  general  and  administrative  (SG&A)  expenses  decreased  by  $3.9  million,  to  $6.7  million  (2021: 
$10.6 million). This decrease was mainly due to the deconsolidation of a subsidiary in 2022. 

Research and development (R&D) expenses decreased by $1.2 million, to $1.4 million (2021: $2.6 million). 
The  decrease  was  primarily  due  to  the  deconsolidation  of  a  subsidiary  in  2022.  The  remainder  of  the 
decrease reflects the net effect from there being no R&D spend at the remaining subsidiaries. 

Net finance cost increased by $1.0 million in 2022 to $3.8 million (2021: $2.8 million). The increase in the 
net cost reflects the impact from the $0.4 million decrease of a convertible note payable due to the fair 
value adjustment. This decrease was offset by the $4.1 million increase of the subsidiary preferred shares 
liability  balance  at  BridgeComm  as  a  result  of  IFRS  13  fair  value  accounting  up  to  the  point  of 
deconsolidation. Lastly,  interest expense,  net of  interest income, was  $0.1 million in  2022 (2021: $0.2 
million).  

Other income increased to $8.4 million (2021: expense of $1.3 million) reflecting $11.4 million of gain on 
deconsolidation of BridgeComm as well as the company’s share of profit of $2.6 million from its associates, 
offset by $5.6 million loss on investments held at fair value.     

As a result of these factors, total comprehensive loss decreased by $13.6 million to $2.7 million (2021: 
$16.3 million). Total comprehensive loss attributed to the equity holders of the Group was $2.6 million 

13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2021: loss of $15.6 million) and $0.1 million loss (2021: $0.7 million) was attributable to the owners of 
non-controlling interests. 

Consolidated Statement of Financial Position 

As of 31 December 

Non-current assets  
Current assets 

     Total assets  

Non-current liabilities 
Current liabilities 
Equity  

 Total liabilities and equity 

2022 
$ '000 

2021 
$ '000 

 34,771 
 7,961 
42,732 

— 
1,152 
41,580 
42,732 

 35,229 
 20,672 
      55,901 

 213 
11,033 
 44,655 
55,901 

Significant  performance-impacting  events  and  business  developments  reflected  in  the  Company’s 
financial position at year end include:  

Non-current assets 

Property  and  equipment  decreased  by  $0.7  million  to  $0.1  million  (2021:  $0.8  million)  The  decrease 
reflects  the  depreciation  expense  of  $0.3  million  as  well  as  impact  from  the  deconsolidation  of 
BridgeComm of $0.5 million in the second half of the year. This was offset by purchases of approximately 
$0.1 million. 

Investments  held  at fair  value  decreased  to $31.7  million (2021: 33.9 million). The change reflects the 
recognition of a $3.2 million investment as a result of the deconsolidation of BridgeComm as well as the 
recognition of $4.2 million in investment as a result of the latest financing round at Federated Wireless. 
This was offset by a loss of $5.3 million of the fair value accounting for other investments held at fair 
value as well as the $4.3 million reduction in investments as a result of the disposal of TouchBistro.  

Investments  in  associates  increased  to  $2.8  million  (2021:  nil).  As  a  result  of  the  deconsolidation  of 
BridgeComm, the company recorded $2.8 million in investments in associates which includes the share of 
profits of $2.6 million generated by BridgeComm as of the date of deconsolidation. 

Right-of-use assets decreased to $0.1 million (2021: $0.4 million) primarily related to depreciation of $0.2 
million and deconsolidation of BridgeComm of $0.1 million.  

Current assets 

Cash and cash equivalents decreased by $1.9 million to $7.8 million (2021: $9.7 million). The decrease is 
mainly attributed to $4.9 million of net cash used in operations, offset by $3.0 million cash provided by 
investing activities and $0.003 million cash used in financing activities. 

Trade and other receivables decreased by $5.8 million to $0.1 million (2021: $5.9 million) primarily due to 
a  cumulative  decrease  in  trade  receivables  and  prepaid  expenses  of  $5.6  million  as  a  result  of 
deconsolidation of BridgeComm in the second half of 2022. 

14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other financial assets have decreased by $5.0 million to $0.1 million (2021: $5.1 million) primarily due to 
the conversion of Federated Wireless's SAFE of $4.3 million into preferred shares upon the closing of the 
Series D  funding  and  a  loss  of  $0.2 million of  the  fair  value  accounting  for  the  note  recorded  prior  to 
conversion. Lastly, the disposal of TouchBistro’s remaining shares held in an escrow worth $0.4 million has 
also contributed to the overall decrease.  

Current liabilities 

Subsidiary  preferred  shares  decreased  by  $1.3  million  to  $nil  (2021:  $1.3  million)  as  a  result  of 
deconsolidation of BridgeComm in the second half of 2022.  

Deferred revenue decreased by $4.9 million to $nil (2021: $4.9 million) as a result of deconsolidation of 
BridgeComm in the second half of 2022. 

Loans  decreased  by  $3.1  million  (2021:  $3.1  million)  primarily  due  to  note  conversion  as  a  result  of 
BridgeComm’s latest financing event in the second half of 2022.  

Non-current liabilities 

Lease  liabilities  decreased  by  $0.7  million  to  $0.1  million  (2021:  $0.8  million)  primarily  due  to 
deconsolidation of BridgeComm and lease payments.  

Equity 

Net equity decreased by $3.1 million to $41.6 million (2021: $44.7 million) reflecting the combination of 
comprehensive loss for the period of $2.7 million, repurchase of ordinary shares of $0.3 million and the 
effect of deconsolidation of BridgeComm of $0.1 million.  

Consolidated Statement of Cash Flows 

For the years ended 31 December 

Net cash outflow from operating activities 
Net cash inflow/(outflow) from investing activities 
Net cash (outflow)/inflow from financing activities 

 Net decrease in cash and cash equivalents 
 Cash and cash equivalents in the beginning of the year 
 Cash and cash equivalents at the end of the year 

2022 
$ '000 

 (4,926) 
 3,037 
 (3) 
 (1,892) 
 9,710 
 7,818 

2021 
$ '000 

 (9,060) 
 (18,749) 
 13,030 
 (14,779) 
 24,489 
9,710 

The Group’s net cash outflow from operating activities of $4.9 million in 2022 (2021: $9.1 million) was 
primarily due to the losses for  the year of $2.5 million and the adjustment for non-cash items such as 
depreciation, amortisation, impairments, share of net loss of associate, gain on deconsolidation, loss on 
investments held at fair value and share-based payment expenses of $8.0 million, offset by the net effect 
from movement in working capital of $2.1 million, other finance charges of $3.5 million. 

The Group had a net cash inflow provided by investing activities of $3.0 million in 2022 (2021: outflow of 
$18.7  million).  This  inflow  was  predominately  related  to  the  $4.3  million  proceeds  from  sale  of 
TouchBistro's investment offset by the $1.2 million investment made in BridgeComm’s Series B-2 funding 
derecognized on deconsolidation of the subsidiary. 

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Group’s net cash outflow from financing activities of $0.003 million in 2022 (2021: inflow of $13.0 
million) reflects, in part, proceeds from issuance of preferred shares in subsidiaries of $0.5 million and $0.4 
million in proceeds from issuance of convertible notes at BridgeComm. The decrease was offset by $0.7 
million in lease payments and $0.2 million payments to repurchase the company’s own shares. 

The Group’s strategy is to maintain highly liquid cash balances that cover its operating expenses while 
focusing on maximising monetisation opportunities for portfolio company interests.  The Group does 
not have any enforceable financial or working capital commitments to any of the portfolio companies.  
The Directors will not deploy any capital into any new portfolio companies.   

In the event of successful monetisation events from the sale of portfolio companies or portfolio 
company interests, the Directors anticipate distributing the net proceeds to shareholders, after due 
consideration of potential follow-on investment opportunities within the existing portfolio and working 
capital requirements.  

To further minimise its exposure to risks the Group does not maintain any material borrowings in 
foreign currency. 

Risk Management  

The execution of the Group’s strategy is subject to a number of risks and uncertainties.  The Board has 
adopted  a  system  of  continuous  review  in  which  it  regularly  consults  with  management  to  identify 
principal and emerging risks facing the Group and to assess and determine how to address and mitigate 
against such risks in a manner consistent with the Company’s risk appetite to achieve its strategic goals.  
Throughout the year, the Board considers and reviews both risks arising from the internal operations of 
the Group, and those arising from the business environment in which it operates.  It is possible that one 
or more of these identified  risks could impact the  Group in a similar timeframe which may  compound 
their effects. 

With our focus on early stage company development,  commercialisation and monetisation, the Group 
inherently  faces  significant  risks  and  challenges.    The  overall  aim  of  the  risk  management  policy  is  to 
achieve an effective balance of risk and reward, although ultimately, no strategy can provide an absolute 
assurance against loss. 

The  Board  has  carried  out  a  robust  assessment  of  the  principal  and  emerging  risks  facing  the  Group, 
including those that would threaten its business model,  future performance, solvency and/or liquidity.  
The major risks and uncertainties identified by the Board are set out below, along with the consequences 
and mitigation strategy of each risk. 

1.  

The science and technology being developed or commercialised by the Group’s businesses may 
fail and/or the Group’s businesses may not be able to develop their innovations and intellectual 
property into commercially viable products or technologies.  There is also a risk that some of the 
portfolio  companies  may  fail  or  not  succeed  as  anticipated,  whether  as  a  result  of  technical, 
product, market, fund-raising or other risks, resulting in an impairment of the Group’s value. 

Impact: The failure of any of the Group’s portfolio companies would impact the Group’s value.  A failure 
of one of the major portfolio companies could also impact  the Group’s reputation  as a builder of high 

16 

 
 
value businesses and possibly make additional fund raising at the Group or portfolio company level more 
difficult. 

Mitigation: 

(cid:120)  Before making any follow-on investment in the current portfolio, extensive due diligence is carried 
out  by  the  Group  which  covers  all  the  major  business  risks  including  market  size,  strategy, 
adoption  and  intellectual  property.    Where  appropriate,  we  seek  validation  through  co-
investment by other strategic and/or financial parties. 

(cid:120)  A  disciplined  approach  to  capital  allocation  is  pursued  whereby  we  closely  monitor  milestone 
developments before  committing  additional  capital.  Should  a project fail to  achieve sufficient 
progress or is unable to attract other co-investors, we may terminate the investment. 

(cid:120)  Dedicated  leadership  with  deep  industry  or  sector  knowledge,  and  relevant  technical  and/or 
leadership experience, is recruited to management positions, and the Group ensures that each 
portfolio  company  has  independent  directors  and/or  other  advisors,  as  appropriate  for  the 
relevant stage of development. 

(cid:120) 

Each  portfolio company  holds board of director meetings  at least quarterly, with  participation 
from  the  Group’s  Directors  along  with  senior  management  and  independent  directors  and/or 
advisors, as appropriate, of such portfolio company. 

(cid:120)  Within  the  Board  there  is  meaningful  operating  and  investment  expertise  that  provide  direct, 
hands-on  and  strategic,  operating  and  fund-raising  support  to  its  portfolio  companies,  as 
appropriate. 

2.  

The  portfolio  companies  expect  to  incur  substantial  expenditure  in  further  research  and 
development, product development, sales and marketing and other operational activities of its 
businesses.  There is no guarantee that the Group or any of its individual portfolio companies will 
become profitable prior to the achievement of a portfolio company sale or other liquidity event, 
and, even if the Group or any of its individual portfolio companies does become profitable, such 
profitability may not be sustainable.  The Group may not be able to attract other co-investors, or 
monetise  its  ownership  interests  in  portfolio  companies,  during  any  specific  time  frame  or 
otherwise on desirable terms, if at all.  

Impact: Allied Minds’ objective is to generate returns for its shareholders through early stage company 
development  within  the  technology  sector.    Such  value  is  expected  to  be  delivered  through  the 
commercialisation and monetisation of these businesses via a sale or other liquidity event for each.  The 
timing and size of these potential inflows is uncertain and, should liquidity events not be forthcoming, or 
in the event that they are achieved at values significantly less than the amount of capital invested, then it 
would be difficult to sustain the current levels of investment in the other portfolio companies.  This would 
lead  to  reduced  participation  in  funding  rounds,  which  will  result  in  a  lower  ownership  position,  or 
potentially impact the ability of a company to raise additional funds.   

17 

 
 
 
 
Mitigation: 

(cid:120)  The  Group  has  close  relationships  with  a  wide  group  of  investors,  including  within  its  current 
shareholder base, and continues to identify and develop strategic and financial relationships for 
co-investing in the Group’s portfolio companies. 

(cid:120)  Non-Executive Directors seek to build and maintain strategic and financial relationships for the 
Group,  and  each  portfolio  company  continually  seeks  to  engage  in  strategic  and  financial 
relationships relevant to  their respective markets and to maintain current information on, and 
awareness of, potential fund-raising and monetisation strategies. 

3.  

A significant portion of the Group’s intellectual property relates to technologies which originated 
in the course of research conducted in, and initially funded by, US universities or other federally-
funded research institutions.  Although the Group has been granted exclusive licenses to use this 
intellectual  property,  there  are  certain  limitations  inherent  in  these  licenses,  for  example  as 
required by the Bayh-Dole Act of 1980, related to trademarks and patent development. 

Impact:  There are certain circumstances where the US government has  rights to utilise  the  underlying 
intellectual property without any economic benefit flowing back to the Group.  In the event that 
this were to happen, this could impact the financial return to the Group on its investment in the 
applicable portfolio companies. 

Mitigation: 

(cid:120)  To the Board’s knowledge, while these so called “march in” rights exist, the US government has 

never had cause to use them. 

(cid:120)  The Group seeks to develop dual use capabilities for the technology it licenses and generally tends 

to avoid use cases directly applicable to government use. 

(cid:120)  This risk is also mitigated through employing experienced technology transfer experts supported 

by our legal team to assess risks that may arise out of this eventuality. 

4.  

Certain of the portfolio companies currently have in place cooperative research and development 
agreements  with  certain  US  Department  of  Defense  laboratories  and  other  federally  funded 
government institutions.  Certain regulatory measures apply to these agreements which restrict 
the export of information and material that may be used for military or intelligence applications 
by  a  non-US  person.    Compliance  with  these  regulatory  measures  may  be  complex  and  limit 
commercial alternatives. 

Impact:  If  certain  portfolio  companies  were  to  breach  restrictions  on  the  use  of  certain  licensed 
technologies,  particularly  those  derived  from  federally  funded  research  facilities,  this  could  materially 
impact upon the Group’s ability to license additional intellectual property from these establishments.  In 
certain circumstances, it may also lead to the termination of existing licenses.  In the event that this were 
to  happen,  this  could  materially  affect  a  number  of  the  Group’s  businesses,  potentially  harm  the 
reputation and standing of the Group and cause the termination of certain important relationships with 
federally funded research institutions. 

18 

 
 
Mitigation: 

(cid:120)  Prior  to  licensing  any  technology  under  these  agreements,  the  Group’s  management  seeks  to 
identify the commercial and other alternatives available for products and services associated with 
such  technology  and  innovations,  and  to  ensure  that  there  are  sufficient  markets  available  to 
justify the capital investment.  

(cid:120)  Prior to the commercialisation process, the Group’s management seeks to obtain all the necessary 
clearances from applicable regulatory bodies to ensure that the export of products based upon 
the licensed IP is strictly in accordance with government guidelines. 

(cid:120) 

(cid:120) 

5.  

The Group, including certain of the portfolio companies, employs a number of individuals with 
experience in working with various government agencies. 

Senior management is fully cognisant of the regulations and sensitivities in relation to this issue, 
in particular with International US’ Traffic in Arms Regulations (ITAR) which regulate the use of 
technologies for export, and has numerous mitigating actions available should issues arise. 

The Group operates in complex and specialised business domains and requires highly qualified 
and experienced management to implement its strategy successfully.  All of the operations of the 
Group  are  located  in  the  United  States,  which  is  a  highly  competitive  employment  market.  
Furthermore, given the relatively small size of the senior management at the corporate level, the 
Group is reliant on a small number of key individuals.  

Impact: There is a risk that the Group may lose key personnel, or fail to attract or retain new personnel.  
The loss of key personnel may negatively affect the Group’s competitive advantage.  

Mitigation: 

6. 

The  Non-Executive  Directors  are  working  with  shareholders  to  ensure  that  appropriate 
compensation and incentive packages are in place to ensure continuity of key personnel. A large 
proportion  of  the  overall  value  of  the  Group’s  businesses  may  be  concentrated  in  a  small 
proportion of the Group’s businesses.  If one or more of the intellectual property rights relevant 
to a valuable business were terminated, this would have a material adverse impact on the overall 
value of the Group’s businesses. 

Impact: The termination of critical IP licenses would materially impact the value of the portfolio company 
and have a consequent effect on the value of the overall Group. 

Mitigation: 

(cid:120) 

In  each  portfolio  company,  the  management  is  specifically  directed  to  pursue  a  policy  of 
generating and patenting additional intellectual property to both provide additional protection 
and create direct IP ownership for the company. 

(cid:120)  Where  possible,  the  Group  seeks  to  negotiate  intellectual  property  ownership  rights  in  any 
research and development agreement it enters into with a network partner, such that the Group 
becomes a part owner of the underlying IP. 

19 

 
 
7.  

The US Investment Company Act of 1940 regulates companies which are engaged primarily in the 
business of investing, reinvesting, owning, holding or trading in securities.  Securities issued by 
companies  other  than  consolidated  partner  companies  are  generally  considered  ‘‘investment 
securities’’ for purposes of the Investment Company Act, unless other circumstances exist which 
actively  involve  the  company  holding  such  interests  in  the  management  of  the  underlying 
company. 

Impact:    If  the  Company  is  deemed  to  be  an  ‘‘investment  company’’  subject  to  regulation  under  the 
Investment Company Act, applicable restrictions could make it impractical for the Group to continue its 
business as contemplated and could have a material adverse effect on its business.  If anything were to 
happen  which  would  cause  the  Company  to  be  deemed  to  be  an  investment  company  under  the 
Investment Company Act, requirements imposed by the Investment Company Act, including limitations 
on capital structure, ability to transact business with portfolio companies and ability to compensate key 
employees, could make it impractical for it to continue its business as currently conducted.    

Mitigation: 

(cid:120)  The Company intends to monitor and conduct its operations so that it will not be deemed to be 

an investment company under the Investment Company Act. 

(cid:120)  The  Company  seeks  to  build  value  through  its  current  portfolio  companies;  it  is  not  engaged 
primarily  in  the  business  of  investing,  reinvesting,  owning,  holding  or  trading  in  securities  and 
does not own or propose to acquire investment securities above prescribed thresholds under the 
Investment Company Act. 

(cid:120)  Currently  the  Company  holds  more  than  20%  of  the  voting  securities  in    two  of  its  portfolio 
companies, which from a value perspective represent the majority of the portfolio and for which 
it continues to maintain significant influence. .  

(cid:120)  The  Company  seeks  to  maintain  significant  influence  in  portfolio  companies  through  a 

combination of the following:  

o  Rights to elect representatives to the board of directors, with ability to exercise influence over 
the  portfolio  company’s  business  strategy,  operating  plans,  budgets  and  key  corporate 
decisions; 

o  Legal  rights,  such  as  access  to  information  (books  and  records)  and  financial  statements, 
liquidation preferences, registrations rights, rights of first refusal, pre-emptive rights and co-
sale rights; and 

o  Protective provisions, such as rights to block certain portfolio company actions. 

8.  

As a result of the Group’s strategy, the Group’s overall success is dependent on a limited, finite 
portfolio of businesses.  If one or more of such businesses were to fail, this would have a material 
adverse impact on the overall value of the Group’s businesses and the Group’s ability to return 
money to shareholders.   

Impact: The failure of one or more remaining Group businesses would materially impact the overall value 
of  the  Group’s  portfolio  and  have  a  consequent  effect  on  the  returns  available  to  shareholders.    This 

20 

 
 
should also be seen in the light of the ongoing cost of living crisis and the impact of high levels of inflation 
in  the  US  and  UK  and  subsequent  increases  in  interest  rates,  which  may  have  an  impact  on  the 
performance and valuation of individual portfolio companies.  

Mitigation: 

(cid:120)  The Board is committed to engaging and working closely with the remaining portfolio companies 

to provide guidance and advice as they navigate funding, operational, and other needs.  

(cid:120)  The  Board  continues  to  monitor  performance,  progress,  and  development  of  each  portfolio 
company  to  critically  assess  the  return  prospects  of  the  remaining  portfolio  and  make 
adjustments as necessary. 

(cid:120)  The  Board  is taking  steps  to  ensure that individual  portfolio companies conserve  cash  and cut 

costs taking into account the current wider economic environment.  

9. 

Given its current cash and financial position, the Group expects to remain operational through 
the  next  three  years.    However,  if  the  Group  is  unable  to  generate  sufficient  revenue, 
appropriately  manage  expenses,  attract  co-investors  to  participate  in  follow-on  portfolio 
company financings, or generate a  sale  or other liquidity event for  any of its existing  portfolio 
companies  or  portfolio  company  interests  prior  to  the  end  of  such  period,  then  the  Group’s 
business,  financial  condition,  results  of  operations,  prospects  and  future  viability  could  be 
adversely affected. 

Impact:  Lack of capital could restrict the Group’s ability to further fund, develop and commercialise its 
existing businesses.  In turn, this could ultimately lead to failure of individual portfolio companies and loss 
of investment as well as failure of the Group as a whole.    

Mitigation: 

(cid:120)  The Board continually seek to build and maintain close relationships with its shareholder base and 
other  strategic  partners  at  the  Group  level,  and  each  portfolio  company  continually  seeks  to 
engage  in  strategic  relationships  relevant  to  their  respective  markets  and  to  maintain  current 
information on and awareness of potential fund-raising and monetisation strategies. 

(cid:120)  The  Company  strives  to  maintain    primary  control  over  all  of  the  portfolio  companies  and/or 
portfolio  company  board  representation,  so  that  it  can  seek  to  influence  optimal  capital 
allocation, use of cash, and fund-raising strategy.   

(cid:120)  The Company has built a valuable portfolio of companies since its inception. 

The Company continuously and critically reviews the progress of its portfolio companies against pre-set 
milestones to ensure its financial capital and human resource is properly allocated to the more promising 
areas of its portfolio to help strengthen and accelerate the Group’s path to monetisation. 

COVID-19 

We continue to closely monitor, assess, and respond to the potential re-emergence of the COVID-19. The 
Group took several actions to enable Allied Minds and its portfolio companies to continue operating safely 

21 

 
 
MANAGEMENT AND GOVERNANCE 

Directors’ Report 

The Directors present their report together with the audited financial statements for Allied Minds plc and 
its subsidiaries for the year ended 31 December 2022.  The Company was incorporated on 15 April 2014 
under the UK Companies Act 2006 (Companies Act). 

Directors 

The  Directors of the Company  as  at 31  December  2022  included  Bruce Failing, Sam Dobbyn,  and  Juan 
Morera.  Casey McDonald resigned as a Non-Executive Director on 9 December 2022.  

None of the Directors were materially interested in any significant contract to which the Company or any 
of its portfolio companies were party during the year. 

Employees 

Following the period end, the Board announced the termination of its employees and the appointment of 
a third party company, Ocorian, to undertake administrative and financial roles.  

Results and Dividends 

During the period, the Group generated a net comprehensive loss after taxation for the year ended 31 
December 2022 of $2.7 million (2021: $16.3 million).  The Directors do not recommend the payment of 
an ordinary dividend for 2022 (2021: nil).   

Strategic Report 

The Group’s Strategic Report can be found on pages 3 to 22 and includes information as to the Group’s 
activities in the field of research and development, and as to the likely future development of the Group.  
Financial key performance indicators can be found on page 12.  

The Strategic Report contains forward-looking statements with respect to the business of Allied Minds.  
These  statements  reflect  the  Board’s  current  view,  are  subject  to  a  number  of  material  known  and 
unknown  events, risks  and uncertainties,  and could change  in  the  future.    Factors that could  cause or 
contribute to such changes include, but are not limited to, anticipated changes to senior management of 
the Company, general economic climate and trading conditions, as well as specific factors relating to the 
financial or commercial prospects or performance of the Group’s individual portfolio companies, and the 
ability to consummate expected fundraising and other transactions. 

Strategic review  

Allied  Minds  is  focused  on  supporting  its  existing  portfolio  companies  and  maximising  monetisation 
opportunities for portfolio company interests. In early 2022 the Board reviewed strategic options available 
to it in order to return value to shareholders.  The Board conducted a “Formal Sale Process" in accordance 
with  Rules  2.4  and  2.6  of  the  Takeover  Code  and  explored  other  strategic  options  such  as  seeking  to 
distribute certain assets and any cash reserves directly back to shareholders through a re-structure. No 
interest was forthcoming as part of the formal sale process.  As part of this strategic review, the Board has 
sought to ensure that the Company is being managed in as cost-efficient manner as possible. In conducting 
this review, the Board considered that the costs of maintaining a premium listing on the Official List and 

23 

 
 
the Main Market of the London Stock Exchange prohibitively high relative to Allied Minds' current size 
and  deemed  maintaining  a  public  listing  was  no  longer  in  the  best  interests  of  the  Company  and  its 
Shareholders as a whole. As a result Shareholders voted on 2 November 2022 to delist the Company and 
trading  on  the  Official  List  and  the  Main  Market  of  the  London  Stock  Exchange  was  cancelled  on  30 
November 2022.  Given the conclusion of the Strategic Review, the Board will continue to aim to monetise 
the Group’s ownership positions at the appropriate time, recognising the value and benefit in achieving 
well-timed  risk-adjusted  returns  for  the  benefit  of  shareholders.  Upon  the  event  of  successful 
monetisation events from the sale of portfolio companies or portfolio company interests, Allied Minds 
anticipates distributing the net proceeds to its shareholders, after due consideration of potential follow-
on investment opportunities within the existing portfolio and working capital requirements.   

Principal and Emerging Risks and Uncertainties and Financial Instruments 

The  Group,  through  its  operations,  is  exposed  to  a  number  of  risks.    The  Group’s  risk  management 
objectives and policies are described on pages 16 to 22.  Further information on the Group’s financial risk 
management objectives and policies, including those in relation to credit risk, liquidity risk and market 
risk, is provided in note 20 to the consolidated financial statements, along with further information on the 
Group’s use of financial instruments.  The pages referenced in this paragraph are incorporated into this 
Directors’ Report by reference. 

Significant Agreements 

The Group has not entered into any significant agreements which may be impacted by a change of control 
following a takeover bid.  

24 

 
 
Share Capital  

Details of the structure of the Company’s share capital and the rights attaching to the Company’s shares 
are set out in note 14 to the consolidated financial statements.  Other than the minimum share ownership 
policy  adopted  by  the  Board  in  April  2016  with  respect  to  Executive  Directors,  there  are  no  specific 
restrictions  on  the  holding  of  securities or  on  the  transfer  of  shares,  which  are  both  governed  by  the 
general provisions of the Company’s Articles of Association (Articles) and prevailing legislation.  None of 
the  ordinary  shares  carry  any  special  rights  with  regard  to  control  of  the  Company  and  there  are  no 
restrictions on voting rights.  

Under the Companies Act, the Company has the power to purchase its own shares in accordance with 
Part 18, Chapter 5 of the Companies Act.  At the 2022 AGM, a special resolution was passed which granted 
the Directors authority to make market purchases of the Company’s shares pursuant to these provisions 
of the Companies Act up to a maximum of approximately 10% of the Company’s issued share capital on 
14 June 2022 provided that the authority granted set a minimum and maximum price at which purchases 
can be made and is exercisable at any time up to the earlier of the conclusion of the next AGM and 30 
September 2023.   

On 17 November 2022, the Company announced the launch of a share buyback programme to repurchase 
shares. This was required to meet the Company’s contractual obligations with staff and directors without 
diluting shareholders. A total of 2,176,229 shares were purchased for a total cost of $0.2 million. Following 
the delisting of its shares from the London Stock Exchange, the Board is not able to repurchase additional 
shares but will seek authority to do so at its forthcoming Annual General Meeting.   

Articles of Association 

The Company’s Articles may be amended by a special resolution of the shareholders. 

Research and Development 

Details  of  the  Group’s  research  and  development  activities  are  included  in  the  Portfolio  Review  and 
Developments section on pages 7 to 11.  

Directors’ Indemnity and Liability Insurance 

During the year, the Company has maintained liability insurance in respect of its directors who held office 
during the period.  Subject to the provisions of the Companies Act, the Articles provide that every director 
is  entitled  to  be  indemnified  out  of  the  funds  of  the  Company  against  any  liabilities  incurred  in  the 
execution or discharge of his or her powers or duties. 

Going concern 

The financial statements and accounts have been prepared on a going concern basis. In determining this 
judgement, and assessed as a period of 12 months from the date the financial statements are approved, 
the directors assess the group’s working capital needs and irrevocably committed financial obligations. 
This considered sensitivities around the Company’s operating costs, taking into account its delisting at the 
end of 2022, and the future capital requirements of its portfolio companies. As stated in the Company 
Overview  on  pages  5  to  7,  the  Directors  remain  focused  on  supporting  our  four  existing  portfolio 
companies and maximising monetisation opportunities for portfolio company interests, and not to deploy 

25 

 
 
any  capital  into  new  portfolio  companies.  This  approach  reflects  the  continuation  of  the  Company’s 
existing strategy and, taken together with significant reductions of its central costs, allows the Company 
to remain viable for the going concern period.  This strategy, pursued to its conclusion, would see the 
Group’s  existing  assets  continue  to  be  managed  and  eventually  monetised,  with  no  new  investments 
being taken on and with a view to returning surplus proceeds to shareholders.  

The Directors carried out an assessment of the principal and emerging risks facing the Group, including 
those that would threaten its business model, future performance, solvency or liquidity, and the other 
principal  and  emerging  risks  detailed  in  the  Strategic  Report.    The  period  under  review  includes  the 
assumption that further funding is not required by the Group in the form of proceeds from either the sale 
of individual portfolio companies, the sale of certain portfolio company interests in secondary  market 
transactions, or a combination thereof.  The Directors believe that a their assessment is most appropriate 
as it aligns with the Group’s normal and well-established budgeting process.  In making their assessment, 
the Directors considered a wide range of information, including present and future economic conditions, 
future projections of profitability, cash flows and capital requirements, and the potential sale of certain 
portfolio company interests in secondary market transactions.  

In summary, the Directors have assessed the Going Concern of the Group over the 12 month period from 
the  date  of  the  annual  report’s  approval.    Based on  this  assessment,  the  Directors  have  a  reasonable 
expectation that the Group will be able to continue in operation and meet its liabilities as they fall due. 

Our Business Ethics and Social Responsibility  

The Group seeks to conduct all of its operating and business activities in an honest, ethical and socially 
responsible manner. We are committed to acting professionally, fairly and with integrity in all our business 
dealings  and  relationships  wherever  we  operate,  and  for  the  Group’s  directors  and  staff  to  have  due 
regard  to  the  interest  of  all  of  its  stakeholders  including  investors,  partners,  employees,  customers, 
suppliers and the businesses in which the Group invests.  We expect our entire workforce to maintain high 
standards in accordance with our internal policies on conduct.  The Company has in place avenues through 
which  employees  can  raise  matters  confidentially  or  anonymously  and  the  Board,  through  the  Audit 
Committee,  regularly  reviews  whistleblowing  reports  provided  by  the  whistleblowing  officer  and  the 
Chairman of the Audit Committee. 

We  take  a  zero  tolerance  approach  to  bribery  and  corruption  and  implement  and  enforce  effective 
systems to counter bribery. The Group is bound by the laws of the UK, including the Bribery Act 2010, and 
has implemented policies and procedures to address such laws, as well as the laws in each jurisdiction 
where the Group operates, including the US. 

Disclosure of Information to Auditor 

Each of the persons who is a Director at the date of approval of this Annual Report confirms that: 

(cid:120) 

(cid:120) 

so far as the Director is aware, there is no relevant audit information  of which the Company’s 
auditor is unaware; and 

the Director has taken all steps that he or she ought to have taken as a Director in order to make 
himself or herself aware of any relevant audit information and to establish that the Company’s 
auditor is aware of that information. 

26 

 
 
This confirmation is given and should be interpreted in accordance with the provisions of Section 418 of 
the Companies Act. 

Annual General Meeting 

The Annual General Meeting (AGM) will be held on 26 July 2023.  The Notice of AGM circulated with this 
Report and Accounts contains a full explanation of the business to be conducted at that meeting.   

Auditors 

In accordance with Section 489 of the Companies Act 2006, a resolution for the appointment of BDO LLP 
as auditor of the Company is to be proposed at the forthcoming AGM. 

Directors’ Responsibilities Statement  

The Directors are responsible for preparing the annual report and the financial statements in accordance 
with applicable law and regulations. 

Company law requires the directors to prepare financial statements for each financial year.  Under that 
law the directors are required to prepare the group financial statements, in accordance with applicable 
law and UK adopted international accounting standards (“IFRS”). 

Under company law the directors must not approve the financial statements unless they are satisfied that 
they give a true and fair view of the state of affairs of the group and company and of their profit or loss 
for that period. 

In preparing these financial statements, the Directors are required to: 

(cid:120) 

select suitable accounting policies and apply them consistently; 

(cid:120)  make judgements and estimates that are reasonable and prudent; 

(cid:120)  provide  additional  disclosures  when  compliance  with  the  specific  requirements  in  IFRSs  are 
insufficient to enable users to understand the impact of particular transactions, other events and 
conditions on the entity’s financial position and financial performance;  

(cid:120)  prepare the financial statements on the going concern basis unless it is inappropriate to presume 

the group will continue in business; and   

(cid:120)  prepare a director’s report, a strategic report and director’s remuneration report which comply 

with the requirements of the Companies Act 2006. 

27 

 
 
 
 
Independent auditor’s report to the members of Allied Minds Plc 

Opinion on the financial statements 

In our opinion: 

(cid:120) 

(cid:120) 

(cid:120) 

(cid:120) 

the financial statements give a true and fair view of the state of the Group’s and of the Parent 
Company’s affairs as at 31 December 2022 and of the Group’s loss for the year then ended; 

the  Group  financial  statements  have  been  properly  prepared  in  accordance  with  UK  adopted 
international accounting standards; 

the Parent Company financial statements have been properly  prepared in accordance with UK 
adopted international accounting standards, and as applied in accordance with the provisions of 
the Companies Act 2006; and 

the  financial  statements  have  been  prepared  in  accordance  with  the  requirements  of  the 
Companies Act 2006. 

We have audited the financial statements of Allied Minds plc (“the Parent Company”) and its subsidiaries 
(“the  Group”)  for  the  year  ended  31  December  2022  which  comprise  the  Consolidated  Statement  of 
Comprehensive  Loss, the Consolidated  Statement of Financial  Position, the Consolidated Statement of 
Changes in Equity, the Consolidated Statement of Cash flows, the Company Balance Sheet, the Company 
Statement  of  Changes  in  Equity,  the  Company  Statement  of  Cash  flows  and  notes  to  the  financial 
statements, including a summary of significant accounting policies. The financial reporting framework that 
has  been  applied  in  their  preparation  is  applicable  law  and  UK  adopted  international  accounting 
standards, and as regards the Parent Company financial statements, as applied in accordance with the 
provisions of the Companies Act 2006.  

Basis for opinion 

We  conducted  our  audit  in  accordance  with  International  Standards  on  Auditing  (UK)  (ISAs  (UK))  and 
applicable  law.  Our  responsibilities  under  those  standards  are  further  described  in  the  Auditor’s 
responsibilities for the audit of the financial statements section of our report. We believe that the audit 
evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

Independence 

We are independent of the Group and the Parent Company in accordance with the ethical requirements 
that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, 
and we have fulfilled our other ethical responsibilities in accordance with these requirements. 

29 

 
 
 
 
Independent auditor’s report to the members of Allied Minds Plc (continued) 

Conclusions relating to going concern 

In auditing the financial statements, we have concluded that the Directors’ use of the going concern basis 
of accounting in the preparation of the financial statements is appropriate. 

Based  on  the  work  we  have  performed,  we  have  not  identified  any  material  uncertainties  relating  to 
events or conditions that, individually or collectively, may cast significant doubt on the Group or Parent 
Company's ability to continue as a going concern for a period of at least twelve months from when the 
financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the Directors with respect to going concern are described 
in the relevant sections of this report. 

Other information 

The Directors are responsible for the other information. The other information comprises the information 
included in the Annual Report, other than the financial statements and our auditor’s report thereon. Our 
opinion  on  the  financial  statements  does  not  cover  the  other  information  and,  except  to  the  extent 
otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. 

Our  responsibility  is  to  read  the  other  information  and,  in  doing  so,  consider  whether  the  other 
information  is  materially  inconsistent  with  the  financial  statements  or  our  knowledge  obtained  in  the 
course  of  the  audit  or  otherwise  appears  to  be  materially  misstated.  If  we  identify  such  material 
inconsistencies or apparent material misstatements, we are required to determine whether this gives rise 
to  a  material  misstatement  in  the  financial  statements  themselves.  If,  based  on  the  work  we  have 
performed, we conclude that there is a material misstatement of this other information, we are required 
to report that fact. 

We have nothing to report in this regard. 

Other Companies Act 2006 reporting 

In our opinion, based on the work undertaken in the course of the audit: 

(cid:120) 

(cid:120) 

the information given in the Strategic report and the Directors’ report for the financial year for 
which the financial statements are prepared is consistent with the financial statements; and 

the Strategic report and the Directors’ report have been prepared in accordance with applicable 
legal requirements. 

In  the  light  of  the  knowledge  and  understanding  of  the  Group  and  the  Parent  Company  and  its 
environment obtained in the course of the audit, we have not identified material misstatements in the 
Strategic report or the Directors’ report. 

30 

 
 
 
 
Independent auditor’s report to the members of Allied Minds Plc (continued) 

We have nothing to report in respect of the following matters in relation to which the Companies Act 
2006 requires us to report to you if, in our opinion: 

(cid:120)  adequate accounting records have not been kept by the Parent Company, or returns adequate for 

our audit have not been received from branches not visited by us; or 

(cid:120) 

(cid:120) 

the Parent Company financial statements are not in agreement with the accounting records and 
returns; or 

certain disclosures of Directors’ remuneration specified by law are not made; or 

(cid:120)  we have not received all the information and explanations we require for our audit. 

Responsibilities of Directors 

As explained more fully in the Statement of Directors Responsibilities, the Directors are responsible for 
the preparation of the financial statements and for being satisfied that they give a true and fair view, and 
for such internal control as the Directors determine is necessary to enable the preparation of financial 
statements that are free from material misstatement, whether due to fraud or error. 

In  preparing  the  financial  statements,  the  Directors are  responsible  for  assessing  the  Group’s  and  the 
Parent Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going 
concern and using the going concern basis of accounting unless the Directors either intend to liquidate 
the Group or the Parent Company or to cease operations, or have no realistic alternative but to do so. 

Auditor’s responsibilities for the audit of the financial statements 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are 
free from  material  misstatement, whether  due  to  fraud  or  error,  and  to  issue an  auditor’s  report  that 
includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an 
audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. 
Misstatements  can  arise  from  fraud  or  error  and  are  considered  material  if,  individually  or  in  the 
aggregate, they could reasonably be expected to influence the economic decisions of users taken on the 
basis of these financial statements. 

Extent to which the audit was capable of detecting irregularities, including fraud 

Irregularities,  including  fraud,  are  instances  of  non-compliance  with  laws  and  regulations.  We  design 
procedures in line with our responsibilities, outlined above, to detect material misstatements in respect 
of  irregularities,  including  fraud.  The  extent  to  which  our  procedures  are  capable  of  detecting 
irregularities, including fraud is detailed below: 

31 

 
 
 
 
Independent auditor’s report to the members of Allied Minds Plc (continued) 

(cid:120)  We identify and assess the risks of material misstatement of the financial statements, whether 
due to fraud or error, and then design and perform audit procedures responsive to those risks, 
including  obtaining audit evidence that is  sufficient  and  appropriate to  provide a basis for  our 
opinion. 

(cid:120)  We have identified and assessed the potential risks related to irregularities, including fraud, by 

considering the following: 

o  Enquiries  of  management  regarding:  the  compliance  with  laws  and  regulations;  the 
detection and response to the risk of fraud and any knowledge of actual, suspected or 
alleged  fraud;  and  the  controls  in  place  to  mitigate  risks  related  to  fraud  or  non-
compliance with laws and regulations; and 

o  Obtaining  an understanding of the legal and regulatory framework in which the Group 
operates. The key laws considered are accounting standards, the Companies Act 2006 and 
tax legislation. 

(cid:120)  We have responded to risks identified by performing procedures including the following: 

o  Enquiry  of  management  and  review  of  legal  correspondence  concerning  actual  and 

potential litigation and claims; 

o  Performing  analytical  procedures  to  identify  any  unusual  or  unexpected  relationships 

which may indicate risks of misstatement due to fraud;  

o  Reading the minutes of meetings of those charged with governance; and 
o  Review of financial statements disclosures and testing to supporting documentation. 

(cid:120)  We have also considered the risk of fraud through management override of controls by: 

o  Testing on a sample basis the appropriateness of journal entries and other adjustments; 

and 

o  Assessing whether the judgements made in making accounting estimates are indicative 

of potential bias.  

Our  audit  procedures  were  designed  to  respond  to  risks  of  material  misstatement  in  the  financial 
statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than 
the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for 
example,  forgery, misrepresentations  or  through  collusion.  There  are  inherent  limitations  in  the  audit 
procedures performed and the further removed non-compliance with laws and regulations is from the 
events and transactions reflected in the financial statements, the less likely we are to become aware of it. 

A further description of our responsibilities is available on the Financial Reporting Council’s  website at 
https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report. 

32 

 
 
 
 
Independent auditor’s report to the members of Allied Minds Plc (continued) 

Use of our report 

This report is made solely to the Parent Company’s members, as a body, in accordance with Chapter 3 of 
Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the 
Parent Company’s members those matters we are required to state to them in an auditor’s report and for 
no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to 
anyone other than the Parent Company and the Parent Company’s members as a body, for our audit work, 
for this report, or for the opinions we have formed. 

Iain Henderson (Senior Statutory Auditor)  
For and on behalf of BDO LLP, Statutory Auditor 
London, UK 
Date: 21 June 2023 

BDO LLP is a limited liability partnership registered in England and Wales (with registered number 
OC305127). 

33 

 
 
 
 
 
 
FINANCIAL STATEMENTS  

CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS 

For the year ended 31 December 

Note 

Revenue 

Operating expenses: 
Cost of revenue 
Selling, general and administrative expenses 

  Research and development expenses 
  Operating loss 

Other income: 

    Gain on deconsolidation of subsidiary 

Loss on investments held at fair value (net) 

  Other income 

  Other income  

Finance income 
Finance cost 
Finance cost from IFRS9/ fair value accounting  

Finance loss, net  

Share of net income/(loss) of associates accounted for using the 
equity method         

Taxation 

Loss before taxation 

Loss for the period 

Other comprehensive loss: 
Items that may be reclassified subsequently to profit or loss: 

Foreign currency translation differences 

  Other comprehensive loss, net of taxation 
Total comprehensive loss for the period 

Loss attributable to: 

Equity holders of the parent 

  Non-controlling interests 

Total comprehensive loss attributable to: 

Equity holders of the parent 

  Non-controlling interests 

3 

4,5 
4,5 
4,5 

10 
10 
17 

7 
7 
7 

      9 

21 

13 

13 

34 

2022 
$ '000 

2021 
$ '000 

1,577 

1,544 

(571) 
(6,703) 
(1,408) 

(7,105) 

11,408 
(5,596) 

— 
5,812 
64 
(201) 
(3,728) 

(3,865) 

2,668 
(2,490) 
— 

(2,490) 

(187) 

(187) 

(2,677) 

(2,461) 
(29) 

(2,490) 

(2,648) 
(29) 

(2,677) 

 (443) 
 (10,569) 
 (2,650) 

(12,118) 

 14,213  
(13,894)  
 705  

1,024 
 45  
 (255) 
 (2,578) 

(2,788) 

(2,362) 
(16,244) 
— 

(16,244) 

(41) 

(41) 

(16,285) 

 (15,534) 
 (710) 

(16,244) 

(15,575) 
(710) 

(16,285) 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
l

a
t
o
T

y
t
i
u
q
e

0
0
0

'

$

-
n
o
N

0
0
0

'

$

s
t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

y
t
i
u
q
e

0
0
0

'

$

t
n
e
r
a
p

l

a
t
o
T

0
0
0

'

$

/
)
t
i
c
i
f
e
D

(

i

s
g
n
n
r
a
E

l

d
e
t
a
u
m
u
c
c
A

0
0
0

'

$

e
v
r
e
s
e
r

n
o
i
t
a
l
s
n
a
r
T

s
e
r
a
h
s
y
r
u
s
a
e
r
T

l

a
t
i
p
a
c
e
r
a
h
S

e
t
o
N

Y
T
I
U
Q
E
N

I
S
E
G
N
A
H
C
F
O
T
N
E
M
E
T
A
T
S
D
E
T
A
D
I
L
O
S
N
O
C

2
2
0
2
r
e
b
m
e
c
e
D
1
3
d
e
d
n
e
r
a
e
y
e
h
t

r
o
F

S
T
N
E
M
E
T
A
T
S
L
A
I
C
N
A
N
I
F

6
8
2

,

8
5

)
4
6
2
2
(

,

)
6
9
(

)
1
4
(

)
4
4
2
6
1
(

,

)
5
8
2
6
1
(

,

)
8
3
7
(

7
0
2

,

3

1
8
2

5
5
6

,

4
4

)
7
8
1
(

)
0
9
4
2
(

,

)
7
7
6
2
(

,

)
8
9
(

)
8
1
(

)
7
3
(

)
5
4
2
(

0
8
5

,

1
4

—

)
0
1
7
(

)
6
9
(

)
0
1
7
(

—

7
0
2

,

3

1
3

8
6
1

—

)
9
2
(

)
9
2
(

)
8
9
(

—

)
8
1
(

)
3
2
(

—

0
5
5
0
6

,

—

)
1
4
(

)
4
3
5

,

5
1
(

)
5
7
5

,

5
1
(

—

0
5
2

)
8
3
7
(

7
8
4
4
4

,

)
7
8
1
(

)
1
6
4

,

2
(

)
8
4
6
2
(

,

—

—

)
4
1
(

)
5
4
2
(

0
8
5
1
4

,

0
4
4

,

5
5

—

)
4
3
5
5
1
(

,

)
4
3
5
5
1
(

,

—

—

—

0
5
2

6
5
1

,

0
4

—

)
1
6
4
2
(

,

)
1
6
4
2
(

,

—

—

—

)
4
1
(

1
8
6

,

7
3

3
4
3

,

1

—

)
1
4
(

)
1
4
(

—

—

—

—

2
0
3

,

1

—

)
7
8
1
(

)
7
8
1
(

—

—

—

—

5
1
1

,

1

—

—

—

—

—

—

—

)
8
3
7
(

)
8
3
7
(

—

—

—

—

—

—

)
5
4
2
(

)
3
8
9
(

t
n
u
o
m
A

0
0
0

'

$

s
e
r
a
h
S

0
0
0

‘

—

—

—

—

—

—

—

)
8
3
5
2
(

,

—

—

—

—

—

—

—

—

—

—

—

—

—

—

7
6
7
3

,

t
n
u
o
m
A

0
0
0

'

$

5
8
9

,

7
8
1

,

2
4
2

s
e
r
a
h
S

)
8
3
5
2
(

,

7
6
7

,

3

5
8
9

,

7
8
1

,

2
4
2

—

—

—

—

—

—

)
6
7
1

,

2
(

—

—

—

—

—

—

—

—

—

—

—

—

—

—

)
4
1
7

,

4
(

7
6
7

,

3

5
8
9

,

7
8
1

,

2
4
2

6

3
1

3
1

2
1

,

3
1

6

3
1

3
1

2
1

,

3
1

r
a
e
y
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c
l

a
t
o
T

0
2
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

r
a
e
y
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

-
n
o
n
n

i

e
g
n
a
h
c
m
o
r
f

g
n
i
s
i
r
a
s
s
o
L

s
n
o
i
t
a
r
e
p
o
g
n
u
n
i
t
n
o
c
m
o
r
f

i

s
s
o
L

n
o
i
t
a
l
s
n
a
r
t
y
c
n
e
r
r
u
c
n
g
e
r
o
F

i

t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

d
o
i
r
e
p
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

s
t
n
e
m
y
a
p
d
e
s
a
b
e
r
a
h
s
d
e
l
t
t
e
s
-
y
t
i
u
q
E

1
2
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

s
n
o
i
t
a
r
e
p
o
g
n
u
n
i
t
n
o
c
m
o
r
f

i

s
s
o
L

n
o
i
t
a
l
s
n
a
r
t
y
c
n
e
r
r
u
c
n
g
e
r
o
F

i

i

s
e
r
a
h
s
y
r
a
n
d
r
o
f
o
e
s
a
h
c
r
u
p
e
R

i

y
r
a
d
i
s
b
u
s

f
o
n
o
i
t
a
d

i
l

o
s
n
o
c
e
D

d
o
i
r
e
p
e
h
t

r
o
f

s
s
o

l

e
v
i
s
n
e
h
e
r
p
m
o
c

l

a
t
o
T

-
n
o
n
n

i

e
g
n
a
h
c
m
o
r
f

g
n
i
s
i
r
a
s
s
o
L

36 

s
t
n
e
m
y
a
p
d
e
s
a
b
e
r
a
h
s
d
e
l
t
t
e
s
-
y
t
i
u
q
E

2
2
0
2
r
e
b
m
e
c
e
D
1
3
t
a
e
c
n
a
a
B

l

i

s
e
r
a
h
s
y
r
a
n
d
r
o
f
o
e
s
a
h
c
r
u
p
e
R

i

y
r
a
d
i
s
b
u
s

f
o
n
o
i
t
a
d

i
l

o
s
n
o
c
e
D

t
s
e
r
e
t
n

i

g
n

i
l
l

o
r
t
n
o
c

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 

2022 

$ '000 

‘2021  
$ '000 

(2,490) 

(16,244) 

8,17 
8 
5,6 
16 
9,18 
9 
9 
8 

11 

15 
15 
3 

7 

8 
9 
17 
9 

16 
16 
17 
12 
14 

507 
— 
(37) 
— 
5,596 
(11,408) 
(2,668) 
— 

289 
539 
207 
413 
573 
12 
(187) 
3,728 

(4,926) 

(71) 
— 
8 
4,322 
(1,222) 

3,037 

400 
— 
(688) 
(245) 
530 

(3) 
(1,892) 
9,710 
7,818 

839 
458 
281 
(443) 
13,894 
(14,213) 
2,362 
(262) 

(96) 
693 
(78) 
(691) 
1,386 
517 
(41) 
2,578 

(9,060) 

(185) 
(5,283) 
45 
— 
(13,326) 

(18,749) 

— 
259 
(1,100) 
(738) 
14,609 

13,030 
(14,779) 
24,489 
9,710 

FINANCIAL STATEMENTS  

CONSOLIDATED STATEMENT OF CASH FLOWS 

For the year ended 31 December 

Cash flows from operating activities: 

Loss for the year 

  Adjustments to reconcile net loss to net cash 

used in operating activities: 
  Depreciation 

Impairment losses on property and equipment 
Share-based compensation expense 
Forgiveness of Paycheck Protection Program (PPP) loan 
Loss on investments held at fair value 
  Gain on deconsolidation of subsidiary 
Share of net (income)/loss of associate 

  Other income 

Changes in working capital: 
  Decrease/(increase) in trade and other receivables 
  Decrease in other assets 

Increase/(decrease) in trade payables 
Increase/(decrease) in accrued expenses 
Increase in deferred revenue 
Increase in other liabilities 
  Unrealised gain on foreign currency transactions 
  Other finance expense 
Net cash used in operating activities 
Cash flows from investing activities: 

Purchases of property and equipment, net of disposals 

  Purchase of investments at fair value 
  Receipt of payment for finance sub-lease 
  Proceeds from sale of investments at FV 
  Cash derecognised upon loss of control over subsidiary 
Net cash provided by/(used in) investing activities 
Cash flows from financing activities: 

Proceeds from issuance of convertible notes 
Receipt of PPP loan 
Payment of lease liability 

  Payments to repurchase ordinary shares 
  Proceeds from issuance of preferred shares in subsidiaries 
Net cash (used in)/provided by financing activities 
Net decrease in cash and cash equivalents, and restricted cash 
Cash and cash equivalents, beginning of the period 
Cash and cash equivalents, end of the period 

37 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 

For the year ended 31 December 2022 

(1)  Accounting Policies 

Basis of Preparation 

Allied Minds Plc (“Allied Minds” or the “Company”) is a company incorporated and domiciled in the UK. 
The Annual Report and Accounts of Allied Minds and its subsidiaries (together referred to as the “Group”) 
are presented for the year ended 31 December 2022. The Group financial statements have been prepared 
and approved by the directors in accordance with UK adopted international accounting standards (“IFRS”) 
for  the  year  ended  31  December  2022.  The  accounting  policies  set  out  below  have,  unless  otherwise 
stated, been applied consistently to all periods presented in these consolidated financial statements. 

On 2 November 2022, Allied Minds passed a matter to cancel the listing of  the  ordinary shares of the 
Company ("Shares") on the Official List of the Financial Conduct Authority ("FCA") and the trading thereof 
on the main market of the London Stock Exchange (the "Delisting Resolution") was voted on by way of a 
poll and was duly passed by the requisite majority of the Company's shareholders. Following the passing 
of the  Delisting Resolution  the  last day of dealings of  the  Shares on the Main Market was Tuesday 29 
November 2022. Cancellation of the listing of the Shares on the Official List of the FCA took effect at 8:00 
am on Wednesday 30 November 2022. 

Basis of Measurement 

The  consolidated financial statements have been prepared  on the historical cost basis  except that the 
following assets and liabilities are stated at their fair value: investments held at fair value and financial 
instruments classified as fair value through the profit or loss. 

Use of Judgments and Estimates 

In preparing these consolidated financial statements, management has made judgments, estimates and 
assumptions that affect the application of the Group’s accounting policies and the reported amounts of 
assets,  liabilities,  income  and  expenses. Actual results  may differ  from  these estimates. Estimates and 
underlying  assumptions  are  reviewed  on  an  on-going  basis.  Revisions  to  estimates  are  recognised 
prospectively. The effects on the amounts recognised in the consolidated financial statements, or on other 
alternative performance measures, is included in the following notes: 

Significant estimates made include: 

(cid:120)  Note 10 and 15 – Valuation of financial instruments measured at fair value through profit/loss: 
There is uncertainty in estimating the fair value of subsidiary note payables, subsidiary preferred 
shares, and convertible note assets and investments carried at fair value through profit and loss 
(FVTPL)  according  to  IFRS  9  at  initial  recognition  and  upon  subsequent  measurement.  This 
includes  determining  the  appropriate  valuation  methodology  and  making  certain  estimates 
including future earnings  potential of the subsidiary businesses, appropriate discount rate and 
earnings  multiple  to  be  applied,  marketability,  the  probability  weighting  of  the  scenarios  and 
other industry and company specific risk factors.  

38 

 
 
FINANCIAL STATEMENTS  

Significant judgements made include:  

(cid:120)  Note 10 – there is judgement in considering whether the power to control the subsidiary exists or 
retaining significant influence as it is dependent on certain factors including the voting power the 
entity exercises over the company, the proportion of seats the company controls on the board 
and the investees dependence on the investor for funding, knowledge and its operations. Further 
to the above the group has considered its position under IFRS10 in respect of whether it is an 
investment entity for the purposes of this standard. Management have reviewed the operations 
of  the  group  in  line  with  the  standard,  and  whilst  there  are  characteristics which  indicate  the 
group could be considered an investment company, the underlying measurement of success for 
the  consolidated  portfolio  investments  is  progress  in  relation  to  key  strategic  milestones  in 
bringing  their  products  to  market  and  not  the  fair  value  of  the  business.  Based  on  this 
management  have  judged  the  business  to  not  be  an  investment  entity  and  consolidate  its 
subsidiaries under IFRS10. 

(cid:120)  Note 10 – as the entities in the group progress they may require further external funding which 
in some scenarios reduces the Group’s shareholding to an extent that it loses control under IFRS 
10  which  results  in  them  no  longer  being  able  to  consolidate  the  entity.  There  is  a  further 
significant judgement in  relation to  whether the shares  are accounted  for  as an investment in 
associate per IAS 28 or as a financial asset per IFRS 9 and therefore held at fair value, i.e. whether 
the  Group  maintain  significant  influence  over  the  Company.  This  judgement  includes,  among 
others, an assessment of whether the Company has representation on the board of directors of 
the investee, whether the Company participates in the policy making processes of the investee, 
whether  there  is  any  interchange  of  managerial  personnel,  whether  there  is  any  essential 
technical  information  provided  to  the  investee  and  if  there  are  any  transactions  between  the 
Company and the investee. 

(cid:120)  Note 15 and 19 – financial instrument liability classification: when determining the classification 
of financial instruments in terms of liability or equity. These judgements include an assessment 
whether  the  financial  instrument  include  any  embedded  derivative  features,  whether  they 
include a contractual obligations upon the Group to deliver cash or other financial assets or to 
exchange financial assets or financial liabilities with another party, and whether that obligation 
will be settled by the Company’s exchanging a fixed amount of cash or other financial assets for a 
fixed number of its own equity instruments. Further information about these critical judgments is 
included below under Financial Instruments. 

(cid:120)  Note 3 – revenue recognition: in determining the correct amount of revenue to be recognised, 
the Directors make estimates of the fair values of each component of a contract to be able to 
allocate the overall consideration to each component based on the relative fair value method or 
make estimates of future costs when applying the inputs method. 

(cid:120)  Note  3  –  timing  of  revenue  recognition:  making  certain  judgements  when  determining  the 
appropriate  accounting  treatment  of  key  customer  contract  terms  in  accordance  with  the 
applicable accounting standards and in determining whether revenue should be recognised at a 
point in time or over a period of time. 

39 

 
 
FINANCIAL STATEMENTS  

Other estimates and judgments: 

Going Concern 

The financial statements and accounts have been prepared on a going concern basis. In determining this 
judgement, and assessed as a period of 12 months from the date the financial statements are approved, 
the directors assess the group’s working capital needs and irrevocably committed financial obligations. 
This considered sensitivities around the Company’s operating costs, taking into account its delisting at the 
end of 2022, and the future capital requirements of its portfolio companies. As stated in the Company 
Overview  on  pages  5  to  7,  the  Directors  remain  focused  on  supporting  our  four  existing  portfolio 
companies and maximising monetisation opportunities for portfolio company interests, and not to deploy 
any  capital  into  new  portfolio  companies.  This  approach  reflects  the  continuation  of  the  Company’s 
existing strategy and, taken together with significant reductions of its central costs, allows the Company 
to remain viable for the going concern period.  This strategy, pursued to its conclusion, would see the 
Group’s  existing  assets  continue  to  be  managed  and  eventually  monetised,  with  no  new  investments 
being taken on and with a view to returning surplus proceeds to shareholders.  

The Directors carried out an assessment of the principal and emerging risks facing the Group, including 
those that would threaten its business model, future performance, solvency or liquidity, and the other 
principal  and  emerging  risks  detailed  in  the  Strategic  Report.    The  period  under  review  includes  the 
assumption that further funding is not required by the Group in the form of proceeds from either the sale 
of individual portfolio companies, the sale of certain portfolio company interests in secondary  market 
transactions, or a combination thereof.  The Directors believe that their assessment is most appropriate 
as it aligns with the Group’s normal and well-established budgeting process.  In making their assessment, 
the Directors considered a wide range of information, including present and future economic conditions, 
future projections of profitability, cash flows and capital requirements, and the potential sale of certain 
portfolio company interests in secondary market transactions.  

In summary, the Directors have assessed the Going Concern of the Group over the 12 month period from 
the  date  of  the  annual  report’s  approval.    Based on  this  assessment,  the  Directors  have  a  reasonable 
expectation that the Group will be able to continue in operation and meet its liabilities as they fall due. 

Basis of Consolidation 

Allied Minds Plc was formed on 15 April 2014 and the consolidated financial statements for each of the 
years ended 31 December 2022 and 2021 comprises the financial statements of Allied Minds Plc and its 
subsidiaries. 

Subsidiaries 

The  financial  information  of  the  subsidiaries  is  prepared  for  the  same  reporting  period  as  the  parent 
Company,  using  consistent  accounting  policies.  Subsidiaries  are  entities  controlled  by  the  Group.  The 
Group controls an entity when it is exposed to, or has rights to, variable returns from its involvement with 
the  entity  and  has  the  ability  to  affect  those  returns  through  its  power  over  the  entity.  The  financial 
statements of subsidiaries are included in the consolidated financial statements from the date that control 
commences  until  the  date  that  control  ceases.  Losses  applicable  to  the  non-controlling  interests  in  a 

40 

 
 
 
 
 
FINANCIAL STATEMENTS  

subsidiary  are  allocated  to  the  non-controlling  interests  even  if  doing  so  causes  the  non-controlling 
interests to have a deficit balance. 

Changes in the Group’s interest in a subsidiary that do not result in a loss of control are accounted for as 
equity  transactions.  Where  the  Group  loses  control  of  a  subsidiary,  the  assets  and  liabilities  are 
derecognised along with any related NCI and other components of equity. Any resulting gain or loss is 
recognised in profit or loss. Any interest retained in the former subsidiary is measured at fair value under 
IFRS 9 when control is lost and it will be assessed whether significant influence remains. Where this is the 
case  the  ongoing  accounting  will  be  under  IAS  28,  if  significant  influence  is  also  lost,  the  remaining 
investment is accounted for under IFRS 9. 

Associates 

Associates  are  those  entities  in  which  the  Group  has  significant  influence,  but  not  control,  over  the 
financial and operating policies. Significant influence is presumed to exist when the Group holds between 
20  and  50  percent  of  the  voting  power  of  another  entity.  It  is  also  evidenced  in  one  or  more  of  the 
following ways: 

representation on the board of directors or equivalent governing body of the investee; 

(cid:120) 
(cid:120)  participation in policy-making processes, including participation in decisions about dividends or 

other distributions; 

(cid:120)  material transactions between the entity and its investee; 
(cid:120) 
interchange of managerial personnel; or 
(cid:120)  provision of essential technical information. 

Associates  are  accounted  for  using  the  equity  method  (equity  accounted  investees)  and  are  initially 
recognised  at  cost.  The  Group’s  investment  includes  goodwill  identified  on  acquisition,  net  of  any 
accumulated impairment losses. The consolidated financial statements include the Group’s share of the 
total comprehensive income and equity movements of equity accounted investees, from the date that 
significant influence commences until the date that significant influence ceases. When the Group’s share 
of losses exceeds its interest in an equity accounted investee, the Group’s carrying amount is reduced to 
$nil or up to additional losses are provided for, and a liability is recognised, to the extent that the entity 
has incurred legal or constructive obligations or made payments on behalf of the associate. Recognition 
of further losses is discontinued except to the extent that the Group has incurred legal or constructive 
obligations  or  made  payments  on  behalf  of  an  investee.  To  the  extent  the  Group  holds  interests  in 
associates that are not providing access to returns underlying ownership interests and are more akin to 
debt like securities, the instrument held by Allied Minds is accounted for in accordance with IFRS 9. 

Transactions eliminated on consolidation 

Intra-group balances and transactions, and any unrealised income and expenses arising from intra- group 
transactions, are eliminated. Unrealised gains arising from transactions with equity-accounted investees 
are eliminated against the investment to the extent of the Group’s interest in the investee. Unrealised 
losses are eliminated in the same way as unrealised gains, but only to the extent that there is no evidence 
of impairment. 

Changes of non-controlling interests 

41 

 
 
 
FINANCIAL STATEMENTS  

Non-controlling interests (‘‘NCI’’) are measured at their proportionate share of the acquiree’s identifiable 
net assets at the acquisition date. Changes in the Group’s interest in a subsidiary that do not result in a 
loss of control are accounted for as equity transactions. 

Changes  of  non-controlling  interests  that  do  not  result  in  a  change  of  control  are  accounted  for  as 
transactions with owners in their capacity as owners and therefore no goodwill is recognised as a result 
of such transactions. The adjustments to non-controlling interests are based on a proportionate amount 
of the net assets of the subsidiary. Any difference between the price paid or received and the amount by 
which non-controlling interests are adjusted is recognised directly in equity and attributed to the owners 
of the parent. 

Functional and Presentation Currency 

These consolidated financial statements are presented in US dollars, which is the functional currency of 
most of the entities in the Group. The parent has a functional currency of GBP. All amounts have been 
rounded to the nearest thousand unless otherwise indicated. 

Foreign Currency 

Transactions in foreign currencies are translated to the respective functional currencies of Group entities 
at  the  foreign  exchange  rate  ruling  at  the  date  of  the  transaction.  Monetary  assets  and  liabilities 
denominated in foreign currencies at the balance sheet date are retranslated to the functional currency 
at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are 
recognised in the consolidated statement of comprehensive loss. Non-monetary assets and liabilities that 
are measured in terms of historical cost in a foreign currency are translated using the exchange rate at 
the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies that 
are stated at fair value are retranslated to the functional currency at foreign exchange rates ruling at the 
dates the fair value was determined. 

The assets and liabilities of foreign operations, including fair value adjustments arising on consolidation, 
are translated to the Group’s presentational currency (US dollar) at foreign exchange rates ruling at the 
balance sheet date. The revenues and expenses of foreign operations are translated at an average rate 
for  the  year  where  this  rate  approximates  to  the  foreign  exchange  rates  ruling  at  the  dates  of  the 
transactions. Exchange differences arising from this translation of foreign operations are reported as an 
item  of  other  comprehensive  income  and  accumulated  in  the  translation  reserve  or  non-  controlling 
interest, as the case may be. When a foreign operation is disposed of, such that control, joint control or 
significant influence (as the case may be) is lost, the entire accumulated amount in the translation reserve, 
net of amounts previously attributed to non-controlling interests, is reclassified to profit or loss as part of 
the  gain  or  loss on  disposal.  When  the  Group  disposes  of only  part  of  its  interest  in  a  subsidiary  that 
includes  a  foreign  operation  while  still  retaining  control,  the  relevant  proportion  of  the  accumulated 
amount  is  reattributed  to  non-controlling  interests.  When  the  Group  disposes  of  only  part  of  its 
investment in a subsidiary or an associate that includes a foreign operation while still retaining significant 
influence or joint control, the relevant proportion  of the cumulative amount is reclassified to profit or 
loss. 

42 

 
 
 
 
FINANCIAL STATEMENTS  

Cash and Cash Equivalents 

Cash and cash equivalents include all highly liquid instruments with original maturities of three months or 
less. 

Financial Instruments 

Classification – Financial Assets  

IFRS 9 contains a classification and measurement approach for financial assets that reflects the business 
model, in which assets are managed, and their cash flow characteristics. IFRS 9 contains three principal 
classification  categories  for  financial  assets:  measured  at  amortised  cost,  fair  value  through  other 
comprehensive income (“FVOCI”) and fair value through profit or loss (“FVTPL”). Under IFRS 9, derivatives 
embedded  in  contracts  where  the  host  is  a  financial  asset  in  the  scope  of  the  standard  are  never 
bifurcated. Instead, the hybrid as a whole is assessed for classification. 

Under IFRS 9 all fair value changes of assets designated as at fair value through profit or loss are generally 
presented in profit or loss. 

Cash and cash equivalents: Represent basic cash balances in banks used to fund operations. These are 
classified as assets at amortised cost under IFRS 9.  

Trade Receivables: Under IFRS 9 trade receivables that do not have a significant financing component have 
to be initially recognised at their transaction price rather than at fair value. The Group initially recognises 
receivables and deposits on the date that they are originated at their transaction price, which is the same 
as their fair value. As such, Trade and other receivables are classified as assets at amortised cost under 
IFRS 9.  

Short-term notes: The short-term note from an associate, since its contractual terms do not consist solely 
of  cash  flow  payments  of  principal  and  interest  on  the  principal  amount  outstanding,  is  initially  and 
subsequently measured at fair value, with changes in fair value recognized through profit or loss under 
IFRS 9. The Group designates the SAFE note assets at FVTPL under IFRS 9. Hence, any gains and losses on 
these notes are recognised in profit or loss and are measured in the same way as investments as fair value 
above. 

Security and other deposits: These generally represent security deposits paid by the Group to landlords as 
part of operating lease commitments. As the Company’s objective is that those deposits will be collected 
back, they are classified as assets at amortised cost under IFRS 9.  

Investments at fair value: Reflect investments made by the Group in non-derivative instruments of the 
investees that are designated in this category or not classified in any other category. These financial assets 
are initially measured at fair value and subsequently re-measured at fair value at each reporting date, and 
on derecognition. The Company elects if the gain or loss will be recognised in the Consolidated Statements 
of Comprehensive Income/ (Loss) in Other Comprehensive Income/ (Loss) or through the profit and loss 
on  an  instrument  by  instrument  basis.  Investments  at  fair  value  are  presented  in  the  Consolidated 
Statements of Financial Position as non-current assets, unless the Group intends to dispose of them within 
12 months after the end of the reporting period. If the investments at fair value continue to be held for 
the same long-term strategic purposes, per the application of IFRS 9, the Group may elect then to classify 
them as FVOCI or FVTPL. The Group classifies them as FVTPL. In this case, all fair value gains and losses 

43 

 
 
FINANCIAL STATEMENTS  

would  be  recognised  in  profit  or  loss  as  they  arise,  increasing  volatility  in  the  Group’s  profits.  These 
financial assets do not have exposure to credit risk and are not considered credit-impaired. As a result, 
there  are  no  adjustments  considered  for  movement  in  credit  risk  as  this  is  not  applicable  within  the 
specific valuation  frameworks  utilised  for  the  fair  values  of  the  Group’s  preferred  stock  assets. To  the 
extent  the  Group  holds  interests  in  associates  that  are  not  providing  access  to  returns  underlying 
ownership  interests  and  are  more  akin  to  debt  like  securities,  the  instrument  held  by  Allied  Minds  is 
accounted for in accordance with IFRS 9. 

Classification – Financial Liabilities  

Under  IFRS  9  all  fair  value  changes  of  liabilities  designated  as  at  fair  value  through  profit  or  loss  are 
generally presented in profit or loss.  

The Group designates the subsidiary preferred shares liability at FVTPL under IFRS 9. Hence, any gains and 
losses on the preferred shares liability are recognised in profit or loss, unless they relate to changes in the 
entity’s own credit risk for financial liability designated as at fair value through profit or loss. The effect of 
changes in the entity’s own credit risk in the fair value of the financial liabilities are presented in other 
comprehensive  income.  For  the  underlying  financial  instruments  no  adjustments  are  considered  for 
movement in credit risk as this is not applicable within the specific valuation frameworks utilized for the 
fair values of the Group’s preferred share liability.  

Trade and other payables and loans are designated at amortised cost under IFRS 9.  

Impairment 

IFRS  9  includes  a  ‘forward  looking  expected  credit  loss’  (“ECL”)  model.  The  impairment  methodology 
applied depends on whether there has been a significant increase in credit risk. For trade receivables, the 
group applies the simplified approach permitted by IFRS 9, which requires expected lifetime losses to be 
recognised from initial recognition of the receivables. 

Financial Instruments Issued by the Group 

Under IAS 32, financial instruments issued by the Group are treated as equity only to the extent that they 
meet the following two conditions: 

(cid:120) 

they include no contractual obligations upon the Group to deliver cash or other financial assets 
or to exchange financial assets or financial liabilities with another party under conditions that are 
potentially unfavourable to the Group; and 

(cid:120)  where the instrument will or may be settled in the Company’s own equity instruments, it is either 
a non-derivative that includes no obligation to deliver a variable number of the Company’s own 
equity  instruments or  is  a derivative  that will  be  settled  by the  Company’s  exchanging  a  fixed 
amount of cash or other financial assets for a fixed number of its own equity instruments. 

To the extent that this definition is not met, the financial instrument is classified as a financial liability. 
Where  the  instrument  so  classified  takes  the  legal  form  of  the  Company’s  own  shares,  the  amounts 
presented in the financial information for share capital and merger reserve account exclude amounts in 
relation to those shares.  

44 

 
 
 
FINANCIAL STATEMENTS  

Where  a financial instrument that contains both equity and financial  liability  components exists,  these 
components are separated and accounted for individually under the above policy. 

Paycheck Protection Program (PPP) loan 

The US CARES Act created the Paycheck Protection Program (PPP) to provide qualifying small businesses 
with necessary funds to support their operations during the COVID-19 pandemic. Entities have to meet 
certain eligibility requirements to receive PPP loans, and they must maintain specified levels of payroll 
and employment to have the loans forgiven. The conditions are subject to audit by the US government, 
but entities that borrow less than $2 million will be deemed to have met the initial eligibility requirements. 

Under IAS 20, Accounting for Government Grants and Disclosure of  Government Assistance,  the initial 
receipt of PPP loans is recognized as a liability. This liability can be derecognized when there is “reasonable 
assurance”  that  the  loan  conditions  will  be  met  and  forgiveness  will  be  granted.  Once  forgiven,  the 
company records the amount as other income. 

Share Capital 

Ordinary shares are classified as equity. The Group considers its capital to comprise share capital, share 
premium, treasury shares, merger reserve, translation reserve, and accumulated deficit.  

Property and Equipment 

Property and equipment is stated at cost less accumulated depreciation and any accumulated impairment 
losses. Cost includes expenditure that is directly attributable to the acquisition of the asset. Assets under 
construction represent machinery and equipment to be used in operations, R&D activities, or to be leased 
to customers once completed. 

When parts of an item of property and equipment have different useful lives, they are accounted for as 
separate  items  (major  components)  of  property  and  equipment.  Depreciation  is  calculated  using  the 
straight-line method over the estimated useful lives of the related assets: 

3 years  
Computers and electronics 
5 years 
Furniture and fixtures 
5 -20 years 
Machinery and equipment 
Not depreciated until transferred into use 
Under construction 
Leasehold improvements 
Shorter of the lease term or estimated useful life of the asset 
Right-of-Use Assets                                     Shorter of the lease term or estimated useful life of the asset  

Depreciation  methods,  useful  lives  and  residual  values  are  reviewed  at  least  annually  and  adjusted  if 
appropriate. 

The Directors have considered the value of fixed assets without revaluing them.  

The Directors are satisfied that the aggregate value of those assets at the time in question is or was not 
less than aggregate amount at which they are or were for the time being stated in the company's accounts. 

Intangible Assets 

Software 

45 

 
 
 
FINANCIAL STATEMENTS  

Software intangible assets that are acquired by the Group and have finite useful lives are measured at 
cost less accumulated amortisation and any accumulated impairment losses. 

Finite-lived intangible assets are amortised on a straight-line basis over their estimated useful lives, from 
the date that they are available for use. Intangible assets which are not yet available for use (and therefore 
not amortised) are tested for impairment at least annually. 

Amortisation 

Amortisation is charged to the consolidated statement of comprehensive loss on a straight-line basis over 
the estimated useful lives of intangible assets unless such lives are indefinite. Intangible assets with an 
indefinite useful life and goodwill are systematically tested for impairment at each balance sheet date. 
Other intangible assets are amortised from the date they are available for use. Amortisation methods, 
useful lives and residual values are reviewed at least annually and adjusted if appropriate. 

The estimated useful lives of the Group’s intangible assets are as follows: 

Software 

Leases 

2 years 

IFRS  16  is  a  single,  on-balance  sheet  lease  accounting  model  for  lessees  and  requires  leases  to  be 
accounted for using a right-of-use model, which recognises that, at the date of commencement, a lessee 
has a financial obligation to make lease payments to the lessor for the right to use the underlying asset 
during the lease term. The lessee recognises a corresponding right-of-use asset related to this right. 

Upon adoption, the Group applied the following practical expedients:  
(cid:120)  excluding initial direct costs from the right-of-use assets;  
(cid:120)  use hindsight when assessing the lease term;  
(cid:120)  not reassessing whether a contract is or contains a lease; and  
(cid:120)  not separating the lease components from the non-lease components in lease contracts.  

The Group accounts for lease payments as an expense on a straight-line basis over the life of the lease 
for:  
(cid:120) 
(cid:120) 

Leases with a term of 12 months or less and containing no purchase options; and  
Leases where the underlying asset has a value of less than $5,000.  

The  lease  liability  is  initially  measured  at  the  present  value  of  the  remaining  lease  payments  at  the 
transition date or date of entering the lease, discounted by using the rate implicit in the lease. If this rate 
cannot be readily determined, the Group used its incremental borrowing rate. The right-of-use asset is 
depreciated on a straight-line basis and the lease liability will give rise to an interest charge. 

Finance leases will continue to be treated as finance leases. In November 2020 the Company relocated its 
corporate  headquarters  as  part  of  management’s  initiative  to  minimise  headquarters  expenses.  As  a 
result, starting November 2020, the Company  entered into a sublease for the remaining period of the 
head lease.  

Under IFRS 16, this sublease led to the de-recognition of the right of use asset and the recognition of an 

46 

 
 
 
 
 
FINANCIAL STATEMENTS  

investment receivable in respect of this sublease. The lease liability remains in respect of the head lease 
as a lease liability on the balance sheet. 

Further information regarding the right of use asset and lease liability can be found in Note 17. 

Taxation 

Tax on the profit or loss for the year comprises current and deferred tax. Tax is recognised in the income 
statement except to the extent that it relates to items recognised directly in equity, in which case it is 
recognised in equity. 

Current Income Tax 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax 
rates enacted or substantially enacted at the reporting date, and any adjustment to tax payable in respect 
of previous years. 

Deferred Income Tax 

Deferred tax is recognised in respect of temporary differences between the carrying amounts of assets 
and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax 
assets are recognised for unused tax losses, unused tax credits and deductible temporary differences to 
the extent that it is probable that future taxable profits will be available against which they can be used. 
Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer 
probable that the related tax benefit will be realised. 

Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when 
they reverse, using tax rates enacted or substantively enacted at the reporting date. 

Deferred  tax  assets  and  liabilities  are  offset  if  there  is  a  legally enforceable  right  to  offset current tax 
liabilities and assets, and they relate to taxes levied by the same tax authority on the same taxable entity, 
or on different tax entities where the Group intends to settle current tax liabilities and assets on a net 
basis or their tax assets and liabilities will be realised simultaneously. 

Deferred taxes are  recognised  in  profit or loss except  to the  extent  that it  relates to items recognised 
directly in equity or in other comprehensive income. 

Impairment 

Impairment of Non-Financial Assets 

Non-financial assets consist of property and equipment and intangible assets with finite lives and such 
intangible assets which are not yet available for use. 

The Group reviews the carrying amounts of its property and equipment and finite-lived intangibles at each 
reporting date to determine whether there is any indication of impairment. If any such indication exists, 
then the asset’s recoverable amount is estimated. Intangible assets which are not yet available for use are 
tested annually for impairment. 

47 

 
 
 
FINANCIAL STATEMENTS  

For impairment testing, assets are grouped together into the smallest group of assets that generates cash 
inflows  from  continuing  use  that  are  largely  independent  of  the  cash  inflows  of  other  assets  or  cash-
generating units (‘‘CGUs’’). 

The recoverable amount of an asset or CGU is the greater of its value in use and its fair value less costs to 
sell. Value in use is based on the estimated future cash flows, discounted to their present value using a 
pre-tax discount rate that reflects current market assessments of the time value of money and the risks 
specific to the asset or CGU. 

An impairment loss is recognised in profit and loss if the carrying amount of an asset or CGU exceeds its 
recoverable amount. Impairment losses are allocated to reduce the carrying amounts of assets in a CGU 
on a pro rata basis. 

Impairment of Financial Assets 

The company recognises loss allowances for expected credit losses (ECLs) on financial assets measured at 
amortised cost. 

The  company  measures  loss  allowances  at  an  amount  equal  to  lifetime  ECL,  except  for  other  debt 
securities and bank balances for which credit risk (i.e. the risk of default occurring over the expected life 
of the financial instrument) has not increased significantly since initial recognition, which are measured 
as 12-month ECL. 

Loss allowances for trade receivables  and contract assets are always measured at an amount equal to 
lifetime ECL. 

When  determining  whether  the  credit  risk  of  a  financial  asset  has  increased  significantly  since  initial 
recognition and when estimating ECL, the company considers reasonable and supportable information 
that is relevant and available without undue cost or effort. This includes both quantitative and qualitative 
information and analysis, based on the company’s historical experience and informed credit assessment 
and including forward-looking information.  

Share-based Payments 

Share-based payment arrangements in which the Parent receive goods or services as consideration for 
their  own  equity  instruments  are  accounted  for  as  equity-settled  share-based  payment  transactions, 
regardless of how the equity instruments are obtained by the Group or its subsidiaries. Grants of equity 
instruments under the subsidiary stock option incentive plans are accounted for as equity-settled in the 
consolidated accounts of the parent and are reflected in equity as a credit to Non-Controlling Interest. 

The  grant  date  fair  value  of  share-based  payment  awards  granted  to  employees  is  recognised  as  an 
employee expense, with a corresponding increase in equity, over the period that the employees become 
unconditionally entitled to the awards. The fair value of the options granted is measured using an option 
pricing  valuation  model,  taking  into  account  the  terms  and  conditions  upon  which  the  options  were 
granted. The amount recognised as an expense is adjusted to reflect the actual number of awards for 
which  the  related  service  and  non-market  vesting  conditions  are  expected  to  be  met,  such  that  the 
amount ultimately recognised as an expense is based on the number of awards that do meet the related 
service and non-market performance  conditions at  the  vesting  date. For  share-based  payment awards 

48 

 
 
FINANCIAL STATEMENTS  

with market or non-vesting conditions, the grant date fair value of the share-based payment is measured 
to reflect such conditions and there is no true-up for differences between expected and actual outcomes. 

Employee Benefits 

Short-term Employee Benefits 

Short-term employee benefit obligations are measured on an undiscounted basis and are expensed as the 
related service is provided. A liability is recognised for the amount expected to be paid if the Group has a 
present  legal  or  constructive obligation  to  pay this amount as a result of  past service provided by  the 
employee, and the obligation can be estimated reliably. 

Defined Contribution Plans 

A  defined  contribution  plan  is  a  post-employment  benefit  plan  under  which  an  entity  pays  fixed 
contributions into a separate entity and has no legal or constructive obligation to pay further amounts. 
Obligations  for  contributions  to  defined  contribution  plans  are  recognised  as  an  employee  benefit 
expense in the periods during which related services are rendered by employees. Prepaid contributions 
are recognised as an asset to the extent that a cash refund or a reduction in future payments is available. 

Phantom Plan 

The Phantom Plan is a cash settled bonus plan. Expense is accrued when it is determined that it is probable 
that a payment will be made and when the amount can be reasonably estimated. 

Provisions 

A  provision  is  recognised  in  the  balance  sheet  when  the  Group  has  a  present  legal  or  constructive 
obligation as a result of a past event, that can be reliably measured and it is probable that an outflow of 
economic benefits will be required to settle the obligation. Provisions are determined by discounting the 
expected future cash flows at a pre-tax rate that reflects risks specific to the liability. 

Revenue Recognition 

The Group recognises revenue to depict the transfer of promised goods to customers in an amount that 
reflects  the  consideration  to  which  it  expects  to  be  entitled  in  exchange  for  those  goods.  In  order  to 
achieve this, the Group uses the five step model outlined in IFRS 15: 1) to identify the contract with the 
customer; 2) identify the performance obligation(s) in the contract; 3) determine the transaction price; 4) 
allocate the transaction price to the performance obligation(s); and 5) recognise revenue when (or as) we 
satisfy the performance obligation(s). 

IFRS  15  implements  a  uniform  method  of  recognising  revenue  based  on  the  actual  contract  and 
performance obligation. Under IFRS 15, revenue is recognised when the Company satisfies a performance 
obligation by transferring a promised good or service to its customer. As such, the amount of revenue 
recognised is the amount allocated to the satisfied performance obligation. A performance obligation may 

49 

 
 
FINANCIAL STATEMENTS  

be satisfied at a point in time (typically for promises to transfer goods to a customer) or over time (typically 
for promises to transfer services to a customer).  

Determining the timing of the transfer of control – at a point in time or over time – requires judgement. 
Based on Group’s assessment, it was concluded that the majority of the Company’s projects that: 

(cid:120)  Render a service is performed on a time and materials basis and revenue is recognised as services 
are  provided  based  on  actual  hours  worked  for  a  set  period.  The  performance  obligations 
identified within these projects are distinct and meet the criteria resulting in transfer of control 
over time.  

(cid:120)  Sell  goods,  revenue  is  recognised  when  the  control  of  the  products  were  transferred  to  the 
customer. The performance obligations identified within these projects are distinct and meet the 
criteria resulting in transfer of control at a point in time.  

Refer to Note 3, "Revenue Recognition," for additional information related to the revenue recognised in 
the consolidated statements of operations. 

Finance Income and Finance Costs 

Finance income mainly comprises interest income on funds invested and foreign exchange gains. Finance 
costs  mainly  comprise  fair  value  movements  on  preferred  share  liabilities,  loan  interest  expense  and 
foreign exchange losses. Interest income and interest payable are recognised as they accrue in profit or 
loss, using the effective interest method. 

Fair Value Measurements 

A number of the Group’s accounting policies and disclosures require the measurement of fair values, for 
both financial and non-financial assets and liabilities. 

When measuring the fair value of an asset or a liability, the Group uses market observable data as far as 
possible. Fair values are categorised into different levels in a fair value hierarchy based on the inputs used 
in the valuation techniques as follows: 

(cid:120)  Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities. 

(cid:120)  Level 2: inputs other than quoted prices included in Level 1 that are observable for the asset or liability, 

either directly (i.e. as prices) or indirectly (i.e. derived from prices). 

(cid:120)  Level 3: inputs for the asset or liability that are not based on observable market data (unobservable 

inputs). 

If the inputs used to measure the fair value of an asset or a liability might be categorised in different levels 
of the fair value hierarchy, then the fair value measurement is categorised in its entirety in the same level 
of the fair value hierarchy as the lowest level input that is significant to the entire measurement. 

The  Group  recognises transfers  between  levels of  the  fair  value  hierarchy  at  the  end  of the  reporting 
period during which the change has occurred. 

The  carrying  amount  of  cash  and  cash  equivalents,  accounts  receivable,  deposits,  accounts  payable, 
accrued expenses and other current liabilities in the Group’s Consolidated Statements of Financial Position 
approximates their fair value because of the short maturities of these instruments. 

50 

 
 
FINANCIAL STATEMENTS  

Operating Segments 

Allied  Minds  determines  and  presents operating  segments  based  on the  information  that  internally  is 
provided  to  the  executive management  team,  the  body  which  is considered  to  be  Allied  Minds’  Chief 
Operating Decision Maker (‘‘CODM’’). 

An operating segment is a component of Allied Minds that engages in business activities from which it 
may earn revenues and incur expenses, including revenues and expenses that relate to transactions with 
any  of  the  Allied  Minds’  other  components.  The  operating  segment’s  operating  results  are  reviewed 
regularly by the CODM to make decisions about resources to be allocated to the segment, to assess its 
performance, and for which discrete financial information is available. 

Newly adopted standards 

New standards and interpretations adopted in the current year that did not have a material impact on the 
Company’s financial statements were as follows: 

Effective date  

1 January 2022  

New standards or amendments  

Onerous contracts - Cost of Fulfilling a Contract (Amendments 
to IAS 37) 

References to Conceptual Framework (Amendments to IFRS 3) 

Property, Plant and Equipment: Proceeds before Intended Use 
(amendments to IAS16 

Improvements 

Annual 
(Amendments to IFRS 1, IFRS 9, IFRS 16 and IAS 41) 

IFRS  Standards  2018-2020 

to 

(2)  New Standards and Interpretations not yet effective 

There are a number of new standards, amendments to standard, and interpretations which have been 
issued by the IASB that are effective in future periods that the group has decided not to adopt early.  

The following amendments are effective for the period beginning 1 January 2022: 

Effective date  

1 January 2023 

New standards or amendments  

IFRS 17 Insurance Contracts 

Disclosure of Accounting Policies (Amendments to IAS 1 and 
IFRS Practice Statement 2) 

Classification 
Liabilities 
current (Amendments to IAS 1) 

of 

as 

Current 

or  Non-

51 

 
 
 
 
 
FINANCIAL STATEMENTS  

Definition of Accounting Estimates (Amendments to IAS 8) 

Deferred Tax related to Assets  and  Liabilities  arising from  a 
Single Transaction (Amendments to IAS 12) 

The  Group  does  not  expect  any  other  standard  issued  by  the  IASB,  but  not  yet  endorsed  by  the  UK 
Endorsement Board (“UKEB”), to have a material impact on the group. 

(3)  Revenue 

Revenue recorded in the Statement of Comprehensive Loss consists of the following: 

For the year ended 31 December: 

Service revenue (and transferred over time) 
Total revenue in Consolidated Statement of Loss 

2022 
$'000 

2021 
$'000 

1,577 
1,577 

1,544 
1,544 

Revenues of $1.6 million (2021: $1.5 million) mainly from non-recurring engineering (NRE) and service 
contracts  within  Bridgecomm,  reflecting  the  early  stage  nature  of  our  portfolio  companies.  As  of  9 
September 2022 (“closing date”), BridgeComm was deconsolidated from the Group’s financial statements 
as  a  result  of  its  Series  B-2  and  Series  B-3  Preferred  Stock  financing  round.  As  a  result  of  the 
deconsolidation,  total  revenue  in  the  Consolidated  Statements  of  Comprehensive  Loss  for  2022  was 
presented as of the closing date.  

Contract Balances  

Contract  liabilities represent  the Group’s obligation  to transfer  products or services  to a customer  for 
which consideration has been received. When applicable, contract assets and liabilities are reported on a 
net basis at the contract level, depending on the contracts position at the end of each reporting period. 
Contract  liabilities  are  included  within  deferred  revenue  on  the  Consolidated  Statement  of  Financial 
Position. At the point of inception all contracts were expected to be completed within 12 months and 
therefore, no discounting of the contract liabilities has been accounted for. 

As of 31 December: 

Deferred revenue, current 

2022 
$'000 
― 

2021 
$'000 
(4,948) 

52 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(4)  Operating Segments  

Basis for Segmentation 

For  management  purposes,  the  Group’s  principal operations  are  currently  organised  in  three  types of 
activities: 

(i) 

(ii) 

Early  stage  companies  –  subsidiary  businesses  that  are  in  the  early  stage  of  their  lifecycle 
characterised by incubation, research and development activities; 

Later  stage  companies  –  subsidiary  businesses  that  have  substantially  advanced  with  or 
completed  their  research  and  development  activities,  are  closer 
lifecycle  to 
commercialisation, and/or have a potential of realising material return on investment through a 
future liquidity event; 

in  their 

(iii)  Minority  holdings  companies  –  reflects  the  activity  related  to  portfolio  companies  other  than 
consolidated subsidiary businesses where the Group has made a minority investment and does 
not control or exercise joint control over the financial and operating policies of those entities. This 
segment will only include the results of entities which were deconsolidated during the accounting 
period. As of 31 December 2022,  this operating segment includes BridgeComm, Inc. profit and 
loss for the period up to deconsolidation on 9 September 2022. 

Minority holdings: During the period there was one deconsolidation. The results of the company up to the 
point of deconsolidation, respectively, is included in the Minority Holdings segment below and included 
the following:  

(cid:120)  BridgeComm, Inc., one of the company’s subsidiaries that was deconsolidated during the second 

half of 2022 as a result of financing events at the company. 

Other operations include the management function of the head office at the parent level of Allied Minds. 

Information about Reportable Segments 

The following provides detailed information of the Group’s reportable segments as of and for the years 
ended 31 December 2022 and 2021, respectively: 

53 

 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

2022 
Statement of Comprehensive Loss 

Revenue 
Cost of revenue 
Selling, general and administrative 
Research and development expenses 

  Other expense 

Finance cost, net  
Share of net loss of associates accounted 
for using the equity method   

Profit/(Loss) for the period 

  Other comprehensive loss 

Total comprehensive 
profit/(loss) 

  Minority 
Holdings 

Other 

   Consolidated 

  Operations 

1,577 
(571) 
(1,456) 
(1,408) 
11,705 
(184) 

― 
9,663 
― 

9,663 

― 
― 
(5,247) 
― 
(5,893) 
(3,681) 

2,668 
(12,153) 
(187) 

(12,340) 

1,577 
(571) 
(6,703) 
(1,408) 
5,812 
(3,865) 

2,668 
(2,490) 
(187) 

(2,677) 

(2,461) 
(29) 

(2,490) 

Total comprehensive loss attributable to: 
Equity holders of the parent 
Non-controlling interests 
Total comprehensive 
profit/(loss) 

9,692 
(29) 

(12,153) 
― 

9,663 

(12,153) 

Statement of Financial Position 
  Non-current assets 
Current assets 

Total assets 

  Non-current liabilities 
Current liabilities 

Total liabilities 
Net assets/(liabilities) 

― 
― 
― 
― 
― 
― 
― 

34,771 
7,961 

42,732 
― 
1,152 
1,152 
41,580 

34,771 
7,961 

42,732 
― 
1,052 
1,052 
41,580 

2021 
Statement of Comprehensive Loss 

Revenue 
Cost of revenue 
Selling, general and administrative 
Research and development expenses 

  Other expense 

Finance cost, net  
Share of net loss of associates accounted 
for using the equity method   
Loss for the period 

  Other comprehensive loss 

Total comprehensive loss 

Later 

  Minority 
Holdings 

Other 

  Operation

Consolidated 

1,544 
(443) 
 (3,089) 
 (2,026) 
520  
15,889 

― 
12,395 
― 

12,395 

― 
― 
(1,875) 
 (624) 
 14,398  
(8,089) 

― 
3,810 
― 

3,810 

― 
― 
(5,605) 
― 
(13,894) 
(10,588) 

(2,362) 
(32,449) 
(41) 

(32,490) 

1,544 
(443) 
 (10,569) 
 (2,650) 
 1,024  
 (2,788) 

(2,362) 
(16,244) 
(41) 

(16,285) 

54 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Total comprehensive loss attributable to: 

Equity holders of the parent 
Non-controlling interests 

 12,209  
 186  

 4,706  
 (896) 

(32,449) 
― 

Total comprehensive loss 

12,395 

3,810 

(32,449) 

Statement of Financial Position 
  Non-current assets 
Current assets 

Total assets 

  Non-current liabilities 
Current liabilities 

Total liabilities 
Net assets/(liabilities) 

820 
6,262 
7,082 
(75) 
(12,820) 
(12,895) 
(5,813) 

― 
― 
― 
― 
― 
― 
― 

34,409 
14,410 
48,819 
(138) 
1,787 
1,649 
50,468 

 (15,534) 
 (710) 

(16,244) 

35,229 
20,672 
55,901 
(213) 
(11,033) 
(11,246) 
44,655 

Early Stage companies comprise those that receive an array of business support resources and services 
from  Allied  Minds  in  order  to  successfully  develop  early  stage  technologies.  In  addition,  all  closed  or 
dissolved subsidiaries were presented in the Early Stage segment up to the time at which they were all 
dissolved. No companies support this definition in 2022. 

Later  Stage  companies  comprise  those  that  have  graduated  from  Early  Stage  by  way  of  further 
advancements in their development as described above. In 2022, BridgeComm was the only subsidiary 
that fell under the Later Stage category. On 9 September 2022, BridgeComm was deconsolidated from 
the Group’s financial statements. Therefore, as of 31 December 2022, no companies fall under Early Stage 
or Later Stage categories. 

The results of the management function of the head office at the parent level of Allied Minds are reported 
separately as Other Operations. As the investment in associate is a parent activity, the share of loss, gain 
on  deconsolidation,  remeasurement  of  the  investments  to  fair  value  and  investment  in  associate  are 
disclosed in the Other Operations segment. 

Summarised information related to the Company’s operating revenues by reporting segment for the years 
ended 31 December 2022 and 2021 is as follows: 

Early Stage 
Later Stage 
Minority 
 Total revenue  

2022 

2021 

Service 
revenue 
― 
― 
1,577 

1,577 

Total 
― 
― 
1,577 

1,577 

Service 
revenue 
― 
1,544 
― 

1,544 

Total 
― 
1,544 
― 

1,544 

In  2022,  Cost  of  revenue  and  Selling,  general  and  administrative  expenses  of  Later  Stage,  Minority 
Holdings  and  Other  Operations  segments  included  depreciation  and  amortisation  expense  of  $nil, 
$173,099, and $109,950, respectively (2021: $374,240, $9,239, and $166,626, respectively). 

55 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
 
FINANCIAL STATEMENTS  

The  proportion  of  net  assets  shown  above  that  is  attributable  to  non-controlling  interest  is  disclosed 
further in note 14. 

Geographic Information 

The  Group  revenues  and  net  operating  losses  for  the  years  ended  31  December  2022  and  2021  are 
considered  to  be  entirely  derived  from  its  operations  within  the  United  States  and  accordingly  no 
additional geographical disclosures are provided. 

(5)  Operating Expenses 

The average number of persons employed by the Group (including Directors) during the year, analysed by 
category, was as follows: 

For the year ended 31 December: 

2022 

2021 

Selling, general and administrative 
Research and development 

Total 

13 
8 

21 

16   
14   

30 

The aggregate payroll costs of these persons were as follows: 

For the year ended 31 December: 

Selling, general and administrative 
Research and development 
Total 

Total operating expenses were as follows: 

For the year ended 31 December: 

Salaries and wages 
Payroll taxes 
Healthcare benefit 
Other payroll cost 
Share-based payments 
Total 

Cost of revenue 
Other SG&A expenses 
Other R&D expenses 
Total operating expenses 

56 

2022 
$'000 

2,775 
985 
3,760 

2022 
$'000 

2,770 
239 
744 
44 
(37) 
3,760 

571 
3,928 
423 
8,682 

2021 
$'000 

4,959 
1,378 
6,337 

2021 
$'000 

4,669 
333 
1,020 
34 
281 
6,337 

443 
5,610 
1,272 
13’662 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Auditor's remuneration 
Audit of these financial statements 
Audit-related assurance services 

2022 
$'000 

360 
105 
465 

2021 
$'000 

430 
96 
526 

The Group recorded an impairment charge on property and equipment of $nil (2021: $0.4 million). 

See  note  6  for  further  disclosures  related  to  share-based  payments  and  note  21  for  management’s 
remuneration disclosures. 

(6)  Share-Based Payments 

UK Long Term Incentive Plan 

Under the UK Long Term Incentive Plan (“LTIP”), awards of Ordinary Shares may be made to employees, 
officers  and  directors,  and  other  individuals  providing  services  to  the  Company  and  its  subsidiaries. 
Awards may be granted in the form of share options, share appreciation rights, restricted or unrestricted 
share awards, performance share awards, restricted share units, phantom-share awards and other share-
based awards. Vesting is subject to the achievement of certain performance conditions  and continued 
services of the participant.  

Awards have been granted under the LTIP based on the following vesting criteria: 

(cid:120)  awards subject to performance conditions based on the Company’s total shareholder return (“TSR”) 

performance or relative total shareholder return (rTSR) performance over a defined of time; 

(cid:120)  awards subject to performance conditions based on a basket of shareholder value metrics (“SVM”). 

Performance is assessed on these measures on a scorecard basis over a defined period of time; 

(cid:120)  awards that vest 100 per cent after a period of time subject to continued service condition only. 

On 10 June 2019, the Board determined to retire the long term incentive plan (LTIP) scheme and therefore 
no future awards will be made to executive directors, management and other employees. Historic awards 
remained outstanding and eligible to vest in accordance with their terms.  A significant majority of the 
outstanding awards are subject to relative total shareholder return (TSR) performance; however, at the 
current share price, the performance criteria of these awards will not be met and therefore, no shares are 
expected to be issued under such awards. 

No shares were issued in respect of historic awards under the LTIP during 2022 (2021: nil Ordinary shares).  

The  share  grants  that  vest  upon  the  occurrence  of  a  market  condition  (i.e. the  TSR  performance)  and 
service condition were adjusted to current market price at the date of the grant to reflect the effect of 
the  market  condition  on  the  non-vested  shares’  value.  The  Company  used  a  Monte  Carlo  simulation 
analysis utilising a Geometric Brownian Motion process with 50,000 simulations to value those shares. 
The model takes into account share price volatilities, risk-free rate and other covariance of comparable 

57 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

UK public companies and other market data to predict distribution of relative share performance. This is 
applied to the reward criteria to arrive at expected value of the TSR awards. 

The share grants that vest only upon the occurrence of a non-market performance condition (i.e. the SVM 
grants) and service condition or upon passage of time were valued at the fair value of the shares on the 
date of the grants the vesting conditions are taken into account. The number of instruments included in 
the measurement of the transaction amount is subsequently adjusted so that, ultimately, the amount of 
recognised share-based expense is based on the number of instruments that eventually vest. None of the 
outstanding awards under the LTIP as of 31 December 2022 are subject to SVM vesting.  

The accounting charge does not necessarily represent the intended value of share-based payments made 
to recipients, which are determined by the Remuneration Committee according to established criteria. 
The share-based payment charge for the fiscal year ended 31 December 2022 related to the UK LTIP was 
$0.1 million (2021: $0.3 million). 

On 17 November 2022, ALM's Board of Directors (the "Board") approved a new share buyback programme 
("Buyback Programme"). The purpose of the buyback programme is to satisfy the Company's obligations 
arising from its 2014 LTIP.  

The programme is expected to purchase up to a maximum aggregate consideration of £225,000 of the 
Company's ordinary shares. Share  purchases took  place  in  open market. As of 31 December  2022, the 
Company purchased 2,176,229 of its Ordinary Shares of £0.01 each ("Ordinary Shares") for a total value 
of $245,027. The Ordinary Shares purchased will be held in treasury until transferred by the Company to 
the directors and employees in satisfaction of awards under the 2014 LTIP. 

U.S. Stock Option/Stock Issuance Plan 

The U.S. Stock Option/Stock Issuance Plan (the “U.S. Stock Plan”) was originally adopted by Allied Minds, 
Inc. (now Allied Minds, LLC) in 2008. The U.S. Stock Plan provides for the grant of share option awards, 
restricted  share  awards,  and  other  awards  to  acquire  common  stock  of  Allied  Minds,  Inc.  (now  Allied 
Minds, LLC). All stock options granted to employees under this plan are equity settled, for a ten-year term. 
Pursuant to the Company’s IPO in 2014, Allied Minds Plc adopted and assumed the rights and obligations 
of Allied Minds, Inc. (now Allied Minds, LLC) under this plan except that the obligation to issue Common 
Stock is replaced with an obligation to issue ordinary shares to satisfy awards granted under the U.S. Stock 
Plan.  As  of  19  June  2014,  the  maximum  number  of  options  reserved  under  the  plan  were  issued  and 
outstanding and as a result of the Company’s IPO in 2014, all issued and outstanding options vested on 
19 June 2014. The Company does not intend to make any further grants under the U.S. Stock Plan. 

No new stock option grants were awarded in 2022 and 2021 under the Allied Minds 2008 Plan.  

As of 31 December 2022 no options were exercised (2021: nil) resulting in $nil (2021: $ nil) additional 
share premium for the period. 

Allied Minds Phantom Plan 

In  2007,  Allied  Minds  established  a  cash  settled  plan  for  Allied  Minds  employees,  also  known  as  its 
Phantom Plan. In 2012, the Board of Directors adopted the Amended and Restated 2007 Phantom Plan. 
Under the terms of the Amended and Restated Plan, upon a liquidity event Allied Minds will allocate 10% 

58 

 
 
FINANCIAL STATEMENTS  

of the value (after deduction of the amount invested by Allied Minds and accrued interest at a rate not 
exceeding 5% per annum) of the invested capital owned by Allied Minds of each operating company to 
the plan account. Upon a liquidity event, plan participants holding units will receive their proportionate 
share of the plan account. The allocated shares at all times remain the sole and exclusive property of Allied 
Minds and holders of units have no rights or interests in Allied Minds.  

Allied Minds has not accrued any expense relating to the Phantom Plan as of 31 December 2022 and 2021. 
Management records an expense relating to this plan when it is probable that a subsidiary will be sold 
and the amount of the payout is reasonably estimable or will be paid out in accordance with the plan. 
Given the current valuation of the investments and the thresholds required for payments to be made, 
management has judged that is unlikely there will be any future payouts in respect of this plan based on 
the position at 31 December 2022. 

Share-based Payment Expense 

The  Group  recorded  share-based  payment credit/ charge  related  to  stock  options  of  approximately 
$36,463  and  $281,471  for  the  years  ended  31  December  2022  and  2021,  respectively.  There  was  no 
income tax benefit recognised for share- based payment arrangements for the years ended 31 December 
2022 and 2021, respectively, due to operating losses.  

The following table provides the classification of the Group’s consolidated share-based payment expense/ 
income as reflected in the Consolidated Statement of Loss: 

 For the year ended 31 December: 

Selling, general and administrative 
Research and development 

Total 

(7)  Finance Cost, Net 

2022 
$'000 

(46) 
9 

(37) 

2021 
$'000 

270 
11 

281 

The following table shows the breakdown of finance income and cost: 

For the year ended 31 December: 

Interest income on:   
 – Bank deposits   
Foreign exchange gain 
  Finance income 

Interest expense on: 
 – Financial liabilities at amortised cost 
Foreign exchange loss   

Finance cost contractual   

Loss on fair value measurement of subsidiary preferred shares  

  Finance cost 
Total finance cost, net 

2022 
$'000 

2021 
$'000 

62 
2 
64 

(113) 
(88) 
(201) 
(3,728) 
(3,929) 
(3,865) 

45 
— 
45 

(250) 
(5) 
(255) 
(2,578) 
(2,833) 
(2,788) 

See note 14 for further disclosure related to subsidiary preferred shares. 

59 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(8)  Property and Equipment 

Information regarding the cost and accumulated depreciation of property and equipment, net, consists 
of the following: 

Cost 

in $'000 

Balance as of 31 December 2020 

Additions 
Disposals 
Impairment 
Deconsolidation of subsidiaries 

Balance as of 31 December 2021 

Additions 
Disposals 

  Deconsolidation of subsidiaries (1) 

Balance as of 31 December 2022 

Accumulated Depreciation 
and Impairment loss 

in $'000 

Balance as of 31 December 2020 

Depreciation 
Disposals 
Deconsolidation of subsidiaries  

Balance as of 31 December 2021 

Depreciation 
Disposals 
Deconsolidation of subsidiaries(1) 

Balance as of 31 December 2022 

Property and equipment, net 

in $'000 
Balance as of 31 December 2021 
Balance as of 31 December 2022 

Machinery 
and 
Equipment 
659 
309 
(347) 
— 
— 
621 
44 
(17) 
             (642) 
6 

Machinery 
and 
Equipment 
(475) 
(221) 
347 
— 
(349) 
(94) 
17 
420 
(6) 

Machinery 
and 
Equipment 
272 
— 

Furniture 
and 
Fixtures 
71 
— 
— 
— 
— 
71 
— 
— 
(1) 
70 

Furniture 
and 
Fixtures 
(17) 
(14) 
— 
— 
(31) 
(14) 
— 
1 
(44) 

Furniture 
and 
Fixtures 
40 
26 

Leasehold 
Improvements 
871 
— 
— 
— 
— 
871 
— 
(846) 
— 
25 

Leasehold 
Improvements 
(636) 
(143) 
— 
— 
(779) 
(86) 
846 
— 
(19) 

Leasehold 
Improvements 
92 
6 

Computers 
and 
Electronics 
708 
15 
— 
— 
(34) 
689 
27 
(273) 
(432) 
11 

Computers 
and 
Electronics 
(394) 
(144) 
— 
21 
(518) 
(89) 
273 
324 
(10) 

Computers 
and 
Electronics 
171 
1 

Under 
Construction 
809 
— 
(139)  
(458) 
— 
212 
— 
— 
(212) 
— 

Under 
Construction 
— 

— 
— 
— 
— 
— 
— 
— 

Total 
3,118 
324 
(486) 
(458) 
(34) 
2,464 
71 
(1,136) 
1,287 
112 

Total 
(1,522) 
(523) 
347 
21 
(1,677) 
(283) 
1,136 
745 
(79) 

Under 
Construction 
212 
— 

Total 
787 
33 

(1)  BridgeComm, Inc., one of the company’s subsidiaries was deconsolidated during the second half of 2022 as a result of 

financing events at the company. 

Impairment of property and equipment of $nil and $0.5 million for the years ended 31 December 2022 
and 2021, respectively, is mainly attributed to the closing of subsidiary companies, which resulted in the 
associated assets being impaired. Impairment of property and equipment is included in selling, general 
and administrative expenses in the consolidated statement of comprehensive income. 

Property and equipment under constructions represents assets that are in the process of being built and 
not placed in service as of the reporting date.  

60 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(9)  Investments  

Group Subsidiaries, associates and investments 

As of 31 December 2022, Allied Minds has five portfolio companies, including associates and investments 
and two holding companies. As at the 31 December 2022 the investments in each of the companies and 
the accounting treatment is summarized below: 

Portfolio company 

Financial instruments held 

Allied Minds LLC 

Ordinary shares 

Allied Minds Securities Corp.  Ordinary shares 

BridgeComm, Inc. 

Ordinary share capital and 
preferred shares 

Concirrus, LTD  

Preferred shares 

61 

Accounting treatment of financial 
instruments 
Consolidated by the group in line 
with IFRS 10 and following 
management assessment of 
significant control. 

Consolidated by the group in line 
with IFRS 10 and following 
management assessment of 
significant control. 

The Group has consolidated the 
company up to the point it lost 
control in BridgeComm due to its 
latest financing event and was no 
longer a majority owner. As a result, 
the company was deconsolidated 
and it retained a minority stake in 
the investment. The ordinary share 
capital ownership means that the 
group has significant influence but 
not control over the entity. 
Therefore, the investment in 
ordinary shares is accounted for by 
the equity method of accounting 
under IAS 28. 
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 

The Group has a minority stake in 
the investment and does not have 
significant influence over the 
company. The investment in 
preferred shares is accounted for at 
fair value through the profit and loss 
under IFRS 9. 

 
 
 
 
 
 
FINANCIAL STATEMENTS  

OcuTerra Therapeutics, Inc. 

Ordinary share capital and 
preferred shares 

Federated Wireless, Inc. 

Ordinary share capital and 
preferred shares 

Orbital sidekick, Inc. 

Preferred shares 

The Group does not have significant 
influence over the company. 
Therefore, the investment in 
ordinary shares is accounted for at 
fair value through the profit and loss 
under IFRS 9.  
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 

The ordinary share capital ownership 
means that the group has significant 
influence but not control over the 
entity. Therefore, the investment in 
ordinary shares is accounted for by 
the equity method of accounting 
under IAS 28. 
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 

No ordinary shares are owned by 
Allied Minds and the directors have 
judged, at the year end, that the 
group does not have significant 
influence over the entity through its 
preferred share holding. 
Preferred share holdings are 
accounted for at fair value through 
profit and loss as investments held 
by the Group under IFRS 9. 

62 

 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

The following outlines the formation of each subsidiary and evolution of Allied Minds’ ownership interest 
over the two year period ended 31 December 2022: 

Inception 
Date 

Location (2) 

Issued and Outstanding 
Ownership percentage 
at 31 December (1)  
2021 
2022 

19/06/14 
21/12/15 

Boston, MA 
Boston, MA 

100.00% 
100.00% 
2 

100.00% 
100.00% 
2 

08/08/12 
09/02/15 

02/08/16 
14/12/10 
10/29/21 

Arlington, VA 
Denver, CO 

32.79% 
49.55% 

42.72% 
81.15% 

San Francisco, CA 
Cambridge, MA 
London, UK 

21.58% 
17.06% 
0.87% 

26.29% 
17.06% 
0.98% 

Active subsidiaries 
Holding companies 
  Allied Minds, LLC  
  Allied Minds Securities Corp.  

  Number of active subsidiaries at 31 December: 

Associates  
  Federated Wireless, Inc. (3) 
  BridgeComm, Inc. (3) 

  Other investments 
  Orbital Sidekick, Inc. (3) 
  OcuTerra Therapeutics, Inc. (3)(4) 
  Concirrus, LTD. (Spark Insights, Inc.) (3) 

Notes: 

(1)  Represents ownership percentage held by Allied Minds Plc based on the equity interest owned in ordinary shares plus 
potential equity interest owned in convertible preference shares. The current percentage ownership of each company 
ordinary share capital is as follows: Allied Minds LLC 100%, Allied Minds Securities Corp. 100%, BridgeComm, Inc. 
98.47%, OcuTerra Therapeutics, Inc. 75.26%, Federated Wireless 91.82%, Orbital Sidekick 0%;  

(2)  Allied Minds LLC, BridgeComm, Inc., OcuTerra Therapeutics, Inc., Federated Wireless, Inc. and Federated Wireless 

Government Solutions, Inc. have a registered office address at CT Corporation System, Corporation Trust Center, and 
1209 Orange Street, Wilmington, DE 19801, United States. Allied Minds Securities Corp. has a registered office 
address at CT Corporation System, 155 Federal Street, Suite 700, Boston, MA 02110, United States. Orbital Sidekick 
Inc. has a registered office at Corporation Service Company, 251 Little Falls Drive, Wilmington, DE 19808. Concirrus, 
LTD. has a registered office address at New City Court, 20 St. Thomas Street, London SE1 9RS. 

(3)  The preferred shares that Allied Minds has in these companies are accounted for under IFRS 9. 
(4)  The common shares that Allied Minds has in these companies are accounted for under IFRS 9. 

The following table summarises the financial information related to the Group’s subsidiaries with material 
non-controlling interests, aggregated for interests in similar entities, and before intra-group eliminations 
for  the  year  ended  2021.  None  was  applicable  for  year-ended  2022  due  to  the  Group’s  last  standing 
subsidiary, BridgeComm, being deconsolidated from its financials as of 9 September 2022.  

63 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

As of and for the year ended 31 December: 

Statement of Comprehensive Loss 

  Revenue 

Income for the year 

  Other comprehensive income 

  Total comprehensive income 

  Comprehensive (loss)/ income attributed 

to NCI 

Statement of Financial Position 

  Non-current assets 
  Current assets 

  Total assets 
  Non-current liabilities 
  Current liabilities 

  Total liabilities 
  Net liabilities 

  Carrying amount of NCI 

Statement of Cash Flows 

  Cash flows from operating activities 
  Cash flows from investing activities 
  Cash flows from financing activities 

2021 
$000 

Later Stage 

1,544 
12,395 
-   
12,395 

186 

 820  
 6,262  
7,082 
 (75) 
 (12,820) 
(12,895) 
(5,813) 

168 

 (2,089) 
 (184)  
 1,387  
(886) 

Minority 
Holdings 

-   
3,810 
-   
3,810 

(896) 

-   
-   
-   
-   
-   
-   
-   

-   

 13,916  
 -   
 (1,186) 
12,730 

Investment in Associates 

At 31 December 2022, the Group has two associates, Federated Wireless  and BridgeComm, which are 
material to the Group and are equity accounted.  

Federated Wireless: As of 31 December 2022, Allied Minds’ ownership percentage went from 42.72% to 
32.79% and continues to be subject to the equity method accounting. No further adjustments were made 
to the investment balance at 31 December 2022. If Federated Wireless subsequently reports profits, Allied 
Minds will resume recognising its share of those profits only after its share of the profits equals the share 
of losses not recognised. 

64 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

  Ownership percentage 

Location 

31 December 2022 

31 December 2021 

Federated Wireless, Inc. 

Arlington, 
VA 

32.79% 

42.72% 

Group’s interest in net assets of investee, beginning of 
period 
Addition in the year 
Share of loss from continuing operations 
Carrying amount for equity accounted investees 
Unrecognised share of losses in associate 
Total outstanding 

31 December 2022 

31 December 2021 

$'000 

$'000 

― 
― 
― 
― 
(82,855) 
(82,855) 

― 
― 
― 
― 
(53,169) 
(53,169) 

BridgeComm:  As  of  9  September  2022,  BridgeComm  was  deconsolidated  from  the  Group’s  financial 
statements as a result of the first closing of its Series B-2 and Series B-3 Preferred Stock financing round. 
Specifically, BridgeComm closed a $2.0 million Series B-2 financing in which both Aeroequity Industrial 
Partners ("AEI") and Allied Minds invested $1 million each (inclusive of previous bridge loans), in order for 
the company to continue operations whilst it seeks to raise further funds from interested investors. In 
order to implement the new ownership structure with AEI, $2.0 million of existing Allied Minds debt with 
BridgeComm was not converted. On that date Allied Minds’ issued and outstanding ownership percentage 
dropped from 81.15% to 49.55%. 

Consequently, since the Company no longer holds a majority of the voting rights in BridgeComm and it 
does not hold a majority on its board of directors, Allied Minds does not exercise effective control over 
BridgeComm  and  therefore,  does  not  meet  the  criteria  for  consolidation  under  IFRS  10.  Upon 
deconsolidation,  Allied  Minds  recognised  the  fair  value  of  the  Series  A  Preferred  Stock  and  Series  B 
Preferred  Stock  (collectively  the  “BridgeComm  Preferred  Stock”)  held  in  BridgeComm,  classified  as  an 
investment  at  fair  value  of  $3.2 million  in  accordance  with  IFRS  9.  The  fair  value  of the  investment  in 
associate at the date  of  deconsolidation  was  based on  the value  implied  from  the  third  party  funding 
round which lead to the loss of control. This is a market based valuation approach.  

Due to Allied Minds Common Stock holdings that have equity-like characteristics, the company’s ordinary 
share capital ownership means that the group has significant influence but not control over the entity. As 
such, the investment is accounted for under IAS 28 and is classified by the Company as an investment in 
associate at an initial balance of $0.2 million. At 31 December 2022, Allied Minds’ investment in common 
stock for BridgeComm was brought to $2.8 million after it was adjusted by the share of income of $2.6 
million generated by the associate for the  period September 9- December 31, 2022. As a  result of the 
deconsolidation, Allied Minds recorded an unrealised gain of $11.4 million in the Consolidated Statements 
of Comprehensive Loss. 

65 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

  Ownership percentage 

Location 

31 December 2022 

31 December 2021 

BridgeComm, Inc. 

Denver, 
CO 

49.55% 

81.15% 

Group’s interest in net assets of investee, beginning of 
period 
Addition in the year 
Share of income from continuing operations 
Carrying amount for equity accounted investees 
Total outstanding 

31 December 2022 

31 December 2021 

$'000 

$'000 

― 
180 
2,668 
2,848 
2,848 

― 
― 
― 
― 
― 

The following is summarised financial information for Federated Wireless and BridgeComm, based on 
their perspective consolidated financial statements prepared in accordance with IFRS: 

BridgeComm 
$'000 

Federated Wireless 
$'000 

2022 

2,817 

799 

617 

9,181 

9,798 

(75) 

(18,211) 
(8,488) 

2021 

2022 

2021 

― 

― 

― 

― 

― 

― 

― 
― 

19,272 

(32,372) 

7,966 

44,666 

52,632 

(2,210) 

(136,818) 
(86,396) 

11,021 

(36,788) 

10,067 

24,209 

34,276 

(4,516) 

(86,607) 
(56,847) 

Revenue 

        Profit/(loss) for the period 

Total non-current assets 

Total current assets 

        Total assets 

Total non-current liabilities 

Total current liabilities 
         Net liabilities 

Investments at fair value 

The Group’s investments at fair value represent securities of portfolio companies where Allied Minds 
holds preferred shares or a minority stake in those companies. These investments are initially measured 
at fair value through profit or loss and are subsequently re-measured at fair value at each reporting date 
and on derecognition. 

The fair value of these investments is derived using the option pricing model (“OPM”), the Probability-
Weighted Expected Return Method (“PWERM”) or a hybrid of the two.  

The key inputs into these valuation models include the equity value of the portfolio company, the term of 
the instrument, risk free rate and volatility.  

66 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

The valuation methodologies utilised for determining the equity value include market approach, income 
approach or cost approach or hybrid of these approaches. Other methodologies such as asset based and 
cash in are also utilised where deemed appropriate. It is noted that in the current year none of the equity 
values were determined using the income approach. 

Other valuation approaches 

In certain cases, the value of a portfolio company is determined using a market instead of income- based 
approach.  

Where there has been a third party funding round in the year this has been used as the implied value of 
the portfolio company or comparable guideline public companies or comparable transactions, adjusted 
for indexation where this is deemed to be appropriate. 

Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, 
reasonable  and  robust,  because  of the  inherent  uncertainty of  valuation,  those  estimated  values  may 
differ significantly from  the  values that  would  have been  used  had a  ready market for the investment 
existed and the differences could be material. 

PWERM and OPM 

The principal methods the Group applies for allocation of value are the PWERM, the OPM as well as a 
hybrid of the two. These models take assumptions such as the equity values, term of the instruments, risk 
free rate and volatility to determine the fair value of each share class.  

The  PWERM  estimates  the  value  of  equity  securities  based  on  an  analysis  of  various  discrete  future 
outcomes, such as an IPO, merger or sale, dissolution, or continued operation as a private enterprise until 
a later exit date. The equity value today is based on the probability-weighted present values of expected 
future investment returns, considering each of the possible outcomes available to the enterprise, as well 
as the rights of each security class. The key judgement relates to probability weighting of the scenarios.  

The OPM treats common stock or derivatives thereof as call options on the enterprise’s value or overall 
equity value. The value of a security is based on the optionality over and above the value securities that 
are senior in the capital structure (e.g. preferred stock), considering the dilutive effects of subordinate 
securities. In the OPM, the exercise price is based on a comparison with the overall equity value rather 
than per-share value. 

67 

 
 
 
 
FINANCIAL STATEMENTS  

Those investments are presented in the below table: 

31 December 
2022 
$'000 
17,922 
2,866 
6,633 
― 

4,313 
― 

Disposals 
$'000 
― 
― 
― 
(4,321) 

― 
― 

Finance 
(income)/cost 
from IFRS 9 fair 
value accounting 
$'000 
(515) 
(366) 
(1,895) 
(9) 

Additions(3) 
$'000 
4,283 
3,232 
― 
― 

(1,963) 
(623) 

― 
― 

31 December 
2021 
$'000 
14,154 
― 
 8,528  
4,330 

6,276 
 696  

31,734 

(4,321) 

(5,371)(2) 

7,515 

33,984  

Federated Wireless, Inc. 
BridgeComm, Inc. 
Orbital Sidekick, Inc. 
TouchBistro, Inc. 
OcuTerra Therapeutics, 
Inc. 
Concirrus, LTD(1) 
Total investments at 
fair value 

(1)  Concirrus balance is adjusted by foreign currency changes for the period.  
(2)  The total balance does not reflect the fair market value change for Federated Wireless's SAFE of $0.2 million prior to 

conversion of the note into Series D preferred shares. See below for more details. 

(3)  Of the total amount presented in the additions column, only $0.5 million was cash used in investing activities related 
to BridgeComm’s latest financing and the remaining balance represents note conversion. See below for more details. 

Federated  Wireless:  The  Company’s  investment  at  fair  value  in  Federated  Wireless  has  changed  from 
$14.2 million, as reported at 31 December 2021, to $17.9 million at 31 December 2022. The increase in 
investment balance primarily relates to the conversion of Federated Wireless's SAFE of $4.3 million into 
preferred  shares  upon  the  closing  of  the  Series  D  funding and  $0.5  million  in the  IFRS  9  fair  value 
accounting during the period. Series A and Series C preferred shares were also adjusted following the anti-
dilution protection option in the event of a down round financing. As such, this resulted in 258,839 more 
shares, Series A and C combined, issued to Allied Minds. 

BridgeComm:  As  of  9  September  2022,  BridgeComm  was  deconsolidated  from  the  Group’s  financial 
statements as a result of the first closing of its Series B-2 and Series B-3 Preferred Stock financing round. 
On that date Allied Minds’ issued and outstanding ownership percentage dropped from 81.15% to 49.55%. 

Consequently, since the Company no longer holds a majority of the voting rights in BridgeComm and it 
does not hold a majority on its board of directors, Allied Minds does not exercise effective control over 
BridgeComm  and  therefore,  does  not  meet  the  criteria  for  consolidation  under  IFRS  10.  Upon 
deconsolidation,  Allied  Minds  recognised  the  fair  value  of  the  Series  A  Preferred  Stock  and  Series  B 
Preferred  Stock  (collectively  the  “BridgeComm  Preferred  Stock”)  held  in  BridgeComm,  classified  as  an 
investment  at  fair  value  of  $3.2 million  in  accordance  with  IFRS  9.  The  fair  value  of the  investment  in 
associate at the date  of  deconsolidation  was  based on  the value  implied  from  the  third  party  funding 
round  which  lead  to  the  loss  of  control.  This  is  a  market  based  valuation  approach.  As  a  result of  the 
deconsolidation, Allied Minds recorded an unrealised gain of $11.4 million in the Consolidated Statements 
of Comprehensive Loss. As of 31 December 2022, Allied Minds investment held at fair value related to its 
Preferred Shares in BridgeComm was valued at $2.9 million. 

68 

 
 
 
 
  
 
 
FINANCIAL STATEMENTS  

Orbital  Sidekick:  On  6  April  2018,  Allied  Minds  made  an  investment  in  Orbital  Sidekick,  a  company 
developing capabilities in aerial and space-based hyperspectral imaging and analytics, initially for the oil 
and gas industry. Allied Minds has significant influence over financial and operating policies of the investee 
by virtue of its large, albeit minority, stake in the company and its representation on the entity’s board of 
directors. Allied Minds only held shares of preferred stock in Orbital Sidekick. The preferred shares held 
by Allied Minds are not equity-like and therefore these fall under the guidance of IFRS 9 and will be treated 
as  a  financial  asset  held  at  fair  value  where  all  movements  to  the  value  of  Allied  Minds’  share  in  the 
preferred stock will be recorded through the Consolidated Statements of Comprehensive Loss. 

As  of  31  December  2022,  Allied  Minds'  ownership  of  Orbital  Sidekick's  issued  share  capital  is  21.58% 
compared to 26.29% at 31 December 2021. As of 31 December 2022, Allied Minds investment held at fair 
value related to its Preferred Shares in Orbital Sidekick was valued at $6.6 million (31 December 2021: 
$8.5million).  

TouchBistro: On 28 March 2022, Allied Minds has completed the disposal of its residual shareholding in 
TouchBistro for $5.5 million CAD ($4.3 million USD) in line with its strategy of monetising its investment 
portfolio. Of the sale proceeds, $3.9 million has been received at the time of the sale. On 23 August 2022 
the remaining TouchBistro shares were released from the escrow account and as a result Allied Minds 
received $0.4 million in proceeds from the pre-arranged sale of these shares. 

OcuTerra Therapeutics: As  of  April 2021,  OcuTerra  Therapeutics was  deconsolidated  from the Group’s 
financial statements as a result of the first closing of its Series B Preferred Stock financing round. On that 
date Allied Minds’ issued and outstanding ownership percentage dropped from 62.67% to 27.58%. 

As of 31 December 2022, Allied Minds' ownership of OcuTerra's issued share capital stayed at 17.06% at 
31  December  2021.  The  Company’s  investment  held  at  fair  value  related  to  its  Preferred  Shares  and 
Common Shares in OcuTerra was valued at $4.3 million (31 December 2021: $6.3 million). 

Concirrus: On 29 October 2021, Allied Minds Plc has disposed of its portfolio company, Spark Insights, Inc. 
to Concirrus, a private UK-based insurance technology company in which Concirrus acquired 100% of the 
shares  of  Spark  in  exchange  for  the  issuance  of  Concirrus’  Series  A1  preferred  shares.  Allied  Minds’ 
ownership percentage in Concirrus is 0.87% at 31 December 2022. Based upon the poor performance in 
2022 experienced by Concirrus the capital the directors determined that the value of the Concirrus stock 
at31 December 2022 was nil.  

Allocation Model Inputs  

Allied Minds holds shares of preferred stock in Federated Wireless and Orbital sidekick and has significant 
influence over financial and operating policies of the investee by virtue of its stake in the companies and 
representation on the entity’s board of directors. Allied Minds holds a minority interest in the ordinary 
share capital of TouchBistro and a minority interest in the preferred share of Concirrus, where significant 
influence is not held. It also hold a minority interest in the ordinary share capital and preferred stock of 
OcuTerra Therapeutics. The preferred shares and ordinary share capital in the investments noted above 
fall  under  the  guidance  of  IFRS  9  and  will  be  treated  as  a  financial  asset  held  at  fair  value  and  all 
movements to the value of Allied Minds’ share of these assets will be recorded through the Consolidated 
Statements of Comprehensive Income/(Loss). The following presents the quantitative information about 

69 

 
 
FINANCIAL STATEMENTS  

the significant unobservable inputs used in the fair value measurement of the Group’s financial assets: 

As of 31 December: 
Volatility 
Time to Liquidity (years) 
Risk-Free Rate 
IPO/M&A/Sale Probability 

Sensitivity Analysis 

2022 
54.0%-72.9% 
0.65 - 2.75 
4.27% - 4.73% 
n/a 

2021 
51.8%-81.2% 
0.75 - 2.75 
0.29% - 0.89% 
0%/ 100%/ n/a  

The following summarises the sensitivity from the assumptions made by the Company in respect to the 
unobservable inputs used in the fair value measurement of the Group’s financial assets. The sensitivities 
provided reflect reasonably possible changes to the key assumptions: 

As of 31 December: 

Input 

Enterprise Value 

Volatility 

Time to Liquidity 

Risk-Free Rate (1) 

Sensitivity range  

Financial assets increase/(decrease) 

2022 
$'000 

2021 
$'000 

-2% 
+2% 
-10% 
+10% 
-6 months 
+6 months 
-0.1%/-0.23% 
5% /0.18% 

 (700) 
 768  
 406  
 (199) 
 (78) 
 (173) 
 (78) 
 (173) 

 (780) 
 677  
 171  
 (79) 
 534  
 (1,756) 
 809 
 (465) 

(1)  Risk-free rate is a function of the time to liquidity input assumption. 

(10) 

Cash and Cash Equivalents 

As of 31 December: 

Bank balances 

Total cash and cash equivalents 

(11) 

Trade and Other Receivables 

As of 31 December: 

Trade receivables  
Prepayments and other current assets 
Total trade and other receivables 

2022 
$'000 

2021 
$'000 

7,818 
7,818 

9,710 
9,710 

2022 
$'000 

2021 
$'000 

—     
61 
61 

434    
5,478    
5,912    

70 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(12) 

Equity 

On 17 November 2022, ALM's Board of Directors (the "Board") approved a new share buyback programme 
("Buyback Programme"). The purpose of the buyback programme is to satisfy the Company's obligations 
arising from its 2014 Long Term Incentive Plan ("LTIP").  

The programme is expected to purchase up to a maximum aggregate consideration of £225,000 of the 
Company's ordinary shares. Share  purchases took  place  in  open market. As of 31 December  2022, the 
Company purchased 2,176,229 of its Ordinary Shares of £0.01 each ("Ordinary Shares") for a total value 
of $245,027. The Ordinary Shares purchased will be held in treasury until transferred by the Company to 
the directors and employees in satisfaction of awards under the 2014 LTIP. 

During 2022 and 2021, there were no options exercised under the U.S. Stock Plan. Additionally, no shares 
(2021: nil shares) were issued to existing and former employees of the Group during the year as result of 
vesting of RSUs under the LTIP.   

The table below explains the composition of equity: 

As of 31 December: 

2022 
$'000 

2021 
$'000 

Equity 
Share capital, $0.01 par value, issued and fully paid 
242,187,985 and 242,187,985, respectively 

Treasury shares 
Translation reserve 
Accumulated profit 

Equity attributable to owners of the Company 

Non-controlling interests 

Total equity 

3,767 

(983) 

1,115 
37,681 
41,580 
— 
41,580 

3,767 

(738) 
1,302 
40,156 
44,487 
168 

44,655 

Holders of Ordinary Shares are entitled to vote, on all matters submitted to shareholders for a vote. Each 
Ordinary Share is entitled to one vote. Each ordinary share is entitled to receive dividends when and if 
declared by the Company’s Board of Directors. The Company has not declared any dividends in 2022.  

Translation reserve comprises all foreign exchange differences arising from the translation of the financial 
statements of foreign operations. 

71 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(13) 

Changes in Non-Controlling Interest (“NCI”) 

The following summarises the changes in the non-controlling ownership interest in subsidiaries by 
reportable segment, calculated on the basis of percentage ownership of non-controlling interest in 
voting stock on an as converted basis, excluding liability classified preferred shares: 

Non-controlling interest as of 31 
December 2019 
Share of comprehensive loss 
Effect of change in Company’s 
ownership interest 
Equity-settled share based payments 
Deconsolidation of subsidiaries  
Non-controlling interest as of 31 
December 2021 
Share of comprehensive loss 
Effect of change in Company’s 
ownership interest 
Equity-settled share based payments 
Deconsolidation of subsidiaries(1)  
Non-controlling interest as of 31 
December 2022 

Early Stage 
$'000 

Later Stage 
$'000 

Consolidated 
$'000 

(3,441) 
2,714  

(58) 
(1) 
786 

—   
—   

—   
—   
—   

—   

1,177 
(3,424) 

(38) 
32 
2,421 

168  
 (29) 
 (98) 

(23) 
(18) 

(2,264) 
(710) 

(96) 
31  
3,207 

168 
 (29) 
 (98) 

(23) 
(18) 

—   

—   

(1)  BridgeComm, Inc., one of the company’s subsidiaries was deconsolidated during the second half of 2022 as a result of 

financing events at the company. 

(14) 

Preferred Shares 

Certain of  the  Group’s  subsidiaries  have  outstanding  preferred  shares  which  have  been  classified  as  a 
subsidiary  preferred  shares  in  current  liabilities  in  accordance  with  IFRS  9  as  the  subsidiaries  have  a 
contractual obligation to deliver cash or other assets to the holders under certain future liquidity events, 
and/or a requirement to deliver an uncertain number of common shares upon conversion. The preferred 
shares do not contain mandatory dividend rights. The preferred shares are convertible into common stock 
of  the  subsidiary  at  the  option  of  the  holder  and  mandatorily  convertible  into  common  stock  of  the 
subsidiary upon a qualified public offering at or above certain value and gross proceeds specified in the 
agreements or upon the vote of the holders of a majority of the subsidiary preferred shares. Under certain 
scenarios  the  number  of  common  stock  shares  receivable  on  conversion  will  change.  The  Group  has 
elected not to bifurcate the variable conversion feature as a derivative liability, but account for the entire 
instrument at fair value through the income statement.   

The preferred shares are entitled to a vote with holders of common stock on an as converted basis. The 
holders  of  the  preferred  shares  are  entitled  to  a  liquidation  preference  amount  in  the  event  of  a 
liquidation  or  a  deemed  liquidation  event  of  the  respective  subsidiary.    The  Group  recognises  the 
subsidiary preferred shares balance upon the receipt of cash financing, and records the change in its fair 
value for the respective reporting period through profit and loss. Preferred shares are not allocated shares 
of the subsidiary losses. 

72 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

As  of 9  September  2022, BridgeComm was  deconsolidated  from the Group’s financial statements as a 
result  of  the  first  closing  of  its  Series  B-2  and  Series  B-3  Preferred  Stock  financing  round.  As  a  result, 
BridgeComm closed a $2.0 million Series B-2 financing in which both Aeroequity Industrial Partners ("AEI") 
and Allied Minds invested $1 million each (inclusive of previous bridge loans). On that date Allied Minds’ 
issued  and outstanding ownership percentage  dropped  from 81.15% to 49.55%.  BridgeComm  Inc. had 
outstanding preferred shares which were classified as subsidiary preferred shares in current liabilities in 
accordance with IFRS 9 as BridgeComm has a contractual obligation to deliver cash or other assets to the 
holders under  certain  future liquidity  events,  and/or a requirement  to deliver an  uncertain  number of 
common  shares  upon  conversion. Upon  deconsolidation, Allied  Minds  recognised  the fair value of the 
Series A Preferred  Stock  and  Series B Preferred  Stock  (collectively the  “BridgeComm Preferred  Stock”) 
held in BridgeComm and were classified as an investment at fair value of $3.2 million in accordance with 
IFRS 9. The fair value of the investment in associate at the date of deconsolidation was based on the value 
implied  from  the  third  party  funding  round  which  lead  to  the  loss  of  control.  This  is  a  market  based 
valuation approach.  

The following summarises the subsidiary preferred shares balance: 

As of 31 December: 

BridgeComm 

Total subsidiary preferred 
shares 

2022 
$'000 

—   

—   

Fair value 
loss under 
IFRS 9 
$'000 

  Disposals 

$'000 

Additions(1)  
$'000 

2021 
$'000 

3,728 

(9,117) 

4,134 

1,255 

3,728 

(9,117) 

4,134 

1,255 

(1)  Of the total amount presented in the additions column, only $0.5 million was cash used in financing activities related 

to BridgeComm’s latest financing and the remaining balance represents note conversion.  

The redemption is conditional on occurrence of uncertain future events beyond the control of the 
Group. The amount that would be payable in case of such events is as follows: 

As of 31 December: 

BridgeComm 

Total liquidation preference 

2022 
$'000 

—     
—     

2021 
$’000 

1,260 

1,260 

The subsidiary preferred shares are measured at fair value through profit/loss (FVTPL) according to IFRS 
9 at initial recognition and upon subsequent measurement. Hence, any gains and losses on the preferred 
shares liability are recognised in profit or loss, unless they relate to changes in the entity’s own credit risk 
for financial liability designated as at fair value through profit or loss. The effect of changes in the entity’s 
own credit risk in the fair value of the financial liabilities are presented in other comprehensive income. 
There were  no adjustments considered for movement in credit risk as this is not applicable within the 

73 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

specific  valuation  frameworks  utilized  for  the  fair  values  of  the  Group’s  preferred  share  liability.   The 
subsidiary  preferred  shares  values  and  movement  in  credit  risk,  if  applicable,  are  being  constantly 
monitored as new information becomes available. For the year ended 31 December 2022, the change in 
fair value of the subsidiary preferred shares is recorded in Finance cost, net in the consolidated statement 
of comprehensive loss. 

(15) 

Trade and Other Payables 

As of 31 December: 

Trade payables 
Accrued expenses 
Other current liabilities 
Trade and other payables, current 

2022 
$'000 

224 
792 
1 
1,017 

2021 
$'000 

210 
525 
326 
1,061 

74 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(16) 

Loans 

As of 31 December: 

Current liabilities - Loans: 
Unsecured loans 
Total loans 

2022 
$'000 

2021 
$'000 

― 
― 

3,109 
3,109 

The terms and conditions of outstanding loans are as follows: 

2022 
$'000 

2021 
$'000 

As of 31 December: 

Unsecured loan(1) 
Total interest bearing 
liabilities 

Currency 

Nominal 
interest 
rate 

Year of 
maturity 

Face value 

Carrying 
amount 

Face value 

Carrying 
amount 

USD 

5.0% 

2021-22 

― 

― 

― 

― 

2,500 

2,500 

3,109 

3,109 

BridgeComm convertible note (1) On 16 December 2020, BridgeComm secured $1.0 million of funding through the issuance of a 
convertible bridge note to Boeing HorizonX Ventures, LLC (“Boeing”). In August 2021, as a result of achieving certain 
development milestones under the JDA with Boeing, BridgeComm secured the remaining $1.5 million of convertible debt from 
Boeing. On 8 June 2022, Allied Minds and AE Industrial HorizonX Venture Fund I, LP (HorizonX), jointly contributed an aggregate 
of $0.8 million of convertible bridge financing to BridgeComm, each contributing $0.4 million. 
On 9 September 2022, BridgeComm closed a $2.0 million Series B-2 financing in which both AEI and Allied Minds invested $1 
million each including the conversion of previous bridge  loans with HorizonX. As a result of this change in ownership holding 
Allied Minds no longer controls BridgeComm and at the date of the transaction it has been deconsolidated from the Group.   

(17) 

Leases 

Office and laboratory space is rented under non-cancellable operating leases. These lease agreements 
contain various clauses for renewal at the Group’s option and, in certain cases, escalation clauses typically 
linked to rates of inflation. 

Right of use asset 

Balance at 1 January  

Additions 

Depreciation 

Deconsolidation 
Balance at 31 December 

2021 
$000s 
651 

192 

 (316) 

 (113) 

414 

2022 
$000s 
414 

― 

(224) 

(72) 
118 

75 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Lease liability 

Balance at 1 January 
Additions 
Cash paid  
Interest expense 
Deconsolidation 

Balance at  31 December 

2022 
$000s 
873 
― 
(688) 
25 
(75) 

135 

2021 
$000s 
1,830 
 192  
 (1,100) 
 71  
 (120)  

873 

The following details the short term and long-term portion of the lease liability as at 31 December 2022: 

Lease liability released in < 1 year 
Lease liability released in over 1 year 
Total Lease Liability 

Amounts recognised in profit or loss 

In thousands of $ 

2022 – Leases under IFRS 16 

Interest on lease liabilities 

Income from sub-leasing right-of-use assets presented in 
‘interest income’ 

Total lease liability 
$000s 
135 
― 
135 

31 December 2022 

688 

8 

76 

 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(18) 

Financial Instruments and Related Disclosures 

The following table shows the carrying amounts and fair values of financial assets and financial liabilities, 
including their levels in the fair value hierarchy: 

As of 31 December 2022: 

Financial assets designated as fair 
value through profit or loss 
Investments at fair value 

Loans and receivables 

Cash and cash equivalents 
Trade and other receivables 
Security and other deposits 

Total 

Financial liabilities measured at 
amortised cost 

Trade and other payables 
Lease liability 

Total 

As of 31 December 2021: 

Financial assets designated as fair 
value through profit or loss 
Investments at fair value 

Convertible note receivable 

Loans and receivables 

Cash and cash equivalents 
Trade and other receivables 
Security and other deposits 

Total 

Financial liabilities designated as fair 
value through profit or loss 
      Convertible notes 

Subsidiary preferred shares 
Financial liabilities measured at 
amortised cost 

Trade and other payables 
Lease liability 

Total 

Carrying 
Amount 

$'000 
Fair value 

Level 1 

Level 2 

Level 3 

 Total 

31,734 

— 

— 

31,734 

31,734 

31,734 

31,734 

$'000 
Fair value 

Level 1 

Level 2 

Level 3 

 Total 

— 

— 

— 

— 
— 

— 

— 

— 

— 
— 

33,984 

33,984 

4,500 

4,500 

38,484 

38,484 

3,109 
1,255 

3,109 
1,255 

— 

— 

4,364 

4,364 

7,818 
61 
120 

39,733 

1,017 
135 
1,152 

Carrying 
Amount 

33,984 

4,500 

9,710 
5,912 
594 

54,700 

3,109 
1,255 

1,061 
873 
6,298 

77 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Total other financials assets were as follows: 

For the year ended 31 December: 

Deposits 
Total 

Convertible note receivable 
Other current assets 
Total  

2022 
$'000 

38 
38 

— 
82 
82 
120 

2021 
$'000 

44 
44 

4,500 
550 
5,050 
5,094 

The fair value of financial instruments that are not traded is determined by using valuation techniques 
that maximise the use of observable market data where it is available and rely as little as possible on entity 
specific  estimates.  If  all  significant  inputs  required  to  fair  value  an  instrument  are  observable,  the 
instrument is included in Level 2. Where the inputs for determining the fair value of financial instruments 
are not based on observable market data, the instrument is included in Level 3. See the assumptions for 
the valuation of the Convertible note receivable as disclosed in note 10 of the financial statements. As 
such, for assumptions used in the fair value measurement of the Group’s convertible notes designated as 
Level 3, see note 17.  

For assumptions used in the fair value measurement of the Group’s subsidiary preferred shares liability 
designated as Level 3, see note 15. For assumptions used in the fair value measurement of Investments 
at fair value designated as Level 3, see note 10. 

Cash and cash equivalents, trade receivables, and trade payables are carried at cost, which approximates 
fair value because of their short-term nature. 

The movement in the convertible loan note assets are presented in the below table: 

31 December 
2021 
$'000 
 4,500 

Disposals 
$'000 
(4,283) 

Movement from 
IFRS 9 fair value 
accounting 
$'000 
(217) 

Additions 
$'000 
― 

31 December 
2022 
$'000 
― 

 4,500 

(4,283) 

(217) 

― 

― 

Federated Wireless, Inc. 
Total convertible loan 
note assets at fair value 

78 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(19) 

Capital and Financial Risk Management 

The  Group’s  policy  is  to  maintain  a  strong  asset  base  so  as  to  maintain  investor,  creditor  and  market 
confidence and to sustain future development of the business. Management monitors the level of capital 
deployed and available for deployment in subsidiary projects. The Board of Directors seeks to maintain a 
balance between the higher returns that might be possible with higher levels of deployed capital and the 
advantages and security afforded by a sound capital position. 

The Group’s executive management and Board of Directors have overall responsibility for establishment 
and oversight of the Group’s risk management framework. The Group is exposed to certain risks through 
its normal course of operations. The Group’s main objective in using financial instruments is to promote 
the commercialisation of intellectual property through the raising and investing of funds for this purpose. 
The Group’s policies in calculating the nature, amount and timing of funding are determined by planned 
future investment activity. Due to the nature of activities and with the aim to maintain the investors’ funds 
secure and protected, the Group’s policy is to hold any excess funds in highly liquid and readily available 
financial instruments and reduce the exposure to other financial risks. 

The Group has exposure to the following risks arising from financial instruments: 

Credit Risk 

Credit risk is the risk of financial loss to the Group if a customer or counterparty to a financial instrument 
fails  to  meet  its  contractual  obligations.  Financial  instruments  that  potentially  subject  the  Group  to 
concentrations  of  credit  risk  consist  principally  of  cash  and  cash  equivalents,  investments  held  at  fair 
value, and trade and other receivables. 

The Group held following balances: 

As of 31 December: 

2022 
$'000 

2021 
$'000 

Cash and cash equivalents 
Investments held at fair value 
Trade and other receivables 
Security and other deposits 

7,818  
31,734  
61  
120 
39,733  

9,710 
33,984 
5,912 
594 
50,200 

Risk control  assesses  the  credit  quality of the  customer,  taking  into  account its financial  position, past 
experience and other factors. Individual risk limits are set based on ratings in accordance with limits set 
by the Board. The utilisation of credit limits is regularly monitored. The credit quality of financial assets 
that are neither past due nor impaired can be assessed by reference to credit ratings (if available) or to 
historical information about counterparty default rates. 

Group policy is to maintain its funds in highly liquid deposit accounts with reputable financial institutions.  

The Group’s investments in preferred stock are accounted for at fair value through profit or loss (FVTPL) 
in accordance with IFRS 9. This measurement is appropriate as these financial assets are not held with the 

79 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

objective to collect contractual cash flows which are solely payments of principal and interest (SPPI) on 
the principal amount outstanding.  The entity is primarily focused on fair value information and uses that 
information  to  assess the asset’s  performance and  to make  decisions. The  subsidiary  preferred shares 
values and movement in credit risk are being constantly monitored as new information becomes available. 

The Group has a concentration of credit risk in respect of its financial assets held at fair value through the 
profit or loss which relate to ordinary and preferred share investments with movements in fair value of 
$5.4 million. These investments are reviewed in detail in note 10. The Group assesses the credit quality of 
customers, taking into account their current financial position. 

The aging of trade receivables that were not impaired was as follows: 

As of 31 December: 

2022 
$'000 

2021 
$'000 

Neither past due nor impaired 
Past due 30-90 days 
Past due over 90 days 
Reserve for bad debt 

―  
―  
―  
―  
―  

434 
―  
―  
―  
434 

An analysis of the credit quality of trade receivables that are neither past due nor impaired is as follows: 

As of 31 December: 

Customers with less than three years of 
trading history with the Group 

Liquidity Risk 

2022 
$'000 

2021 
$'000 

―  
―  

434 
434 

Liquidity risk is the risk that the Group will encounter difficulty in meeting the obligations associated with 
its financial liabilities that are settled by delivering cash or another financial asset. The Group’s approach 
to managing liquidity is to ensure, as far as possible, that it will have sufficient liquidity to meet its liabilities 
when they are due, under both normal and stressed conditions, without incurring unacceptable losses or 
risking damage to the Group’s reputation. 

The Group seeks to manage liquidity risk, ensuring that sufficient liquidity is available to meet foreseeable 
requirements. 

The following are the remaining contractual maturities of financial liabilities at the reporting date. The 
amounts are gross and undiscounted, and include estimated interest payments and exclude the impact 
of netting agreements.  

80 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

As of 31 December 2022: 

$'000 

Trade and other payables 
Lease liability  

Carrying 
amount 

1,017 
135 
1,152 

Total 

1,017 
135 
1,152 

Contractual cash flows 

Less than 
1 year  

2-5 years 

  More than 
5 years 

1,017 
135 
1,152 

— 
— 
— 

— 
— 
— 

As of 31 December 2021: 

Contractual cash flows 

$'000 

Trade and other payables 
Convertible loan notes 
Subsidiary preferred shares 
Lease liability  

Carrying 
amount 

Total 

Less than 
1 year  

2-5 years 

  More than 
5 years 

1,061 
3,109 
1,255 
873 
6,298 

1,061 
3,109 
1,255 
873 
6,298 

1,061 
3,109 
1,255 
660 
6,085 

—     
—     
—     
213 
213 

—     
—     
—     
—     
—     

It is not expected that the cash flows included in the maturity analysis could occur significantly earlier, or 
at significantly different amounts. 

Market Risk 

Market risk is the risk that changes in market prices – such as foreign exchange rates, interest rates and 
equity prices – will affect the Group’s income or the value of its holdings of financial instruments. The 
objective of market risk management is to manage and control market risk exposures within acceptable 
parameters,  while  optimising  the  return.  The  Group  maintains  the exposure  to  market  risk  from  such 
financial instruments to insignificant levels. The Group exposure to changes in interest rates is determined 
to be insignificant. 

Capital Risk Management 

The Group is funded by equity finance and long term borrowings. Total capital is calculated as ‘total equity’ 
as shown in the consolidated statement of financial position. 

The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going 
concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain 
an  optimal  capital  structure  to  reduce  the  cost  of  capital.  In  order  to  maintain  or  adjust  the  capital 
structure, the Group may issue new shares or borrow new debt. The Group has some external debt in the 
form of  preferred  shares and no material externally  imposed  capital  requirements.  The Group’s share 
capital is set out in note 15. 

81 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(20) 

Related Parties 

Transactions with Key Management Personnel 

Key Management Personnel Compensation 

Key management personnel compensation received comprised the following: 

For the year ended 31 December: 

 Short-term employee benefits   
 Share-based payments   

Total 

2022 
$'000 
271 
—  
271 

2021 
$'000 
18 
—  
18 

Short-term employee benefits of the Group’s key management personnel include salaries and bonuses, 
health care and other non-cash benefits. 

Share-based payments include the value of awards granted under the LTIP during the year. Share-based 
payments under the LTIP are subject to vesting terms over future periods. See further details of the two 
plans in note 6. 

Key Management Personnel Transactions 

Directors’ remuneration for the year comprised the following: 

For the year ended 31 December: 

Executive Directors’ fees 
Non-executive Directors' fees 

 Total 

2022 
$'000 
—  
271 
271 

2021 
$'000 
18  
345 
363 

Executive management and Directors of the Company control 0.6% of the voting shares of the Company 
as of 31 December 2022 (2021: 0.6 %). 

The Group has not engaged in any other transactions with key management personnel or other related 
parties. 

82 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(21) 

Taxation 

Amounts recognised in profit or loss 

No current income tax expense was recorded for the years ended 31 December 2022 and 2021 due to 
accumulated losses.  

For the year ended 31 December: 

Net income/(loss) 
Income taxes 
Net income/(loss) before taxes 

Reconciliation of Effective Tax Rate 

2022 
$'000 

(2,490) 
—  
(2,490) 

2021 
$'000 

(16,244) 
—  
(16,244) 

The Group is primarily subject to taxation in the US, therefore the reconciliation of the effective tax rate 
has been prepared using the US statutory tax rate. A reconciliation of the US statutory rate to the effective 
tax rate is as follows: 

US federal statutory rate 
Effect of state tax rate in US 
Research credits 
Share-based payment remeasurement 
Permanent differences from consolidation 
Other permanent differences 
Current year income/(losses) for which no deferred  
tax asset/(liability) is recognised 

2022 
% 

2021 
% 

21.0 
6.5 
—  
0.5 
131.6 
(15.9) 

(143.7) 
—  

21.0 
5.7 
1.4 
(0.5) 
52.7 
2.2 

(82.5) 
—  

Factors that may affect future tax expense 
The Group is subject to taxation in the US and UK. Additionally, the Group is exposed to state taxation in 
various jurisdictions throughout the US. Changes in corporate tax rates can change both the current tax 
expense (benefit) as well as the deferred tax expense (benefit). A UK corporation tax rate of 25% (effective 
1 April 2023) was substantively enacted on 23 May 2022, increasing the rate from 19% to 25% for future 
periods.  

83 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

Unrecognised Deferred Tax Assets 

Deferred tax assets have not been recognised in respect of the following items, due to history of operating 
losses and no convincing evidence that future taxable profit will be available against which the Group can 
use the benefits therefrom, as well as due to potential permanent restrictions under Internal Revenue 
Code Section 382 rules: 

As of 31 December: 

Tax loss carry forward  
Research credits  
Temporary differences  
Deferred tax assets 

Other temporary differences  
Deferred tax liabilities 

Deferred tax assets, net, not recognised 

2022 
$’000 

2021 
$'000 

80,719 
4,328 
10,487 
95,534 
—  
—  
95,534 

74,282    
5,201    

24,291    

103,774    
— 
— 
103,774    

Deferred  tax  is  measured  at  the  rates  that  are  expected  to  apply  in  the  period  when  the  temporary 
differences are expected to reverse, based on tax rates and laws that have been enacted or substantially 
enacted by the statement of financial position date.  

As  of  31  December  2022  the  Company  had  United  States  federal  net  operating  losses  carry  forwards 
(“NOLs”) of approximately $258.6 million (2021: $277.6million) available to offset future taxable income, 
if any.  These carryforwards start to expire in 2024 and are subject to review and possible adjustment by 
the  Internal  Revenue  Service.    Additionally,  at  31  December  2022  the  Company  has  capital  loss  carry 
forwards  in  the  amount of $57.0 million  (2021: $8.8 million). These  capital loss carryforwards  start to 
expire in 2023 and are subject to review and possible adjustment by the Internal Revenue Service.  The 
Company may be subject to limitations under  Section 382 of the Internal Revenue Code as a result of 
changes in ownership. The Company’s preliminary analysis on the impact from Section 382  limitations 
suggests that there is unlikely to be a material restriction on NOLs. A detailed exercise is ongoing.  Upon 
the completion of the study, there may or may not be limitations on the Company’s ability to utilise its 
current NOLs against future profits, although these are not expected to be material. 

(22) 

Subsequent Events 

On 6 March 2023,  Concirrus Holdings Limited Concirrus) has purchased Allied Minds’ entire issued share 
capital of 61,252 Ordinary Shares in the Company at a total consideration of £0.46 per share. As a result, 
this transaction fully liquidates Allied Minds' investment in Concirrus. 

On 6 March 2023, Orbital Sidekick, Inc. (OSK) issued an additional 903,276 shares of Series A Preferred 
Stock, pursuant to that certain Series A Preferred Stock Purchase Agreement, dated September 30, 2022, 
raising additional external capital totaling $2.7 million. 

On 24 March 2023, BridgeComm issued $1.5million in convertible notes to AE Industrial HorizonX Venture 
Fund I, LP (HorizonX). The financing will be applied to support the business to the completion of a new 
financing round. 

84 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total 

equity 

$'000 

94,453 

(59,394) 

150,080 

—     

4,179 

4,179 

— 

— 

— 

(38,177) 

(38,177) 

(4,796) 

(617) 

(42,973) 

(38,794)  

— 

— 

250 

— 

 (738) 

250 

(55,215)   

107,357   

55,171 

—     

5,161    

5,161    

— 

— 

(2,316)   

(10,907)   

(2,316)   

(5,746)   

(13,223)   

(8,062)   

— 

(14) 

(245) 

(14) 

(50,054)   

94,120 

46,850  

FINANCIAL STATEMENTS  

COMPANY STATEMENT OF CHANGES IN EQUITY 

Share capital 

Treasury shares 

Share 

Translation 

Accumulated 

Shares 

Amount 

Shares 

Amount 

premium 

reserve 

reserves 

$'000 

‘000 

$' 000 

$'000 

$'000 

$'000 

For the year ended 31 
December 2022 

Balance at 31 December 
2020 

Total comprehensive loss for 
the year 

Loss for the year 
Foreign currency 
translation 

Total comprehensive loss for 
the year 

Issuance of ordinary 
shares 
Repurchase of ordinary 
shares 
Equity-settled share 
based payments 
Balance at 31 December 
2021 

Total comprehensive loss for 
the year 

Loss for the year 
Foreign currency 
translation 

Total comprehensive loss for 
the year 

Repurchase of ordinary 
shares 
Equity-settled share 
based payments 
Balance at 31 December 
2022 

242,187,985 

3,767    

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

 (2,538) 

 (738) 

— 

— 

242,187,985 

3,767    

 (2,538) 

 (738) 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

 (2,176) 

 (245) 

— 

— 

242,187,985 

3,767    

 (4,714) 

 (983) 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

— 

86 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

COMPANY STATEMENT OF CASH FLOWS 

For the year ended 31 December: 

Cash flows from operating activities: 
  Net operating loss for the year 
  Adjustments to reconcile net loss to net cash 

used in operating activities: 

Share-based compensation expense 
Impairment loss in loan to subsidiary 
Changes in working capital: 
  Decrease/(increase) in trade and other receivables 
Increase/(decrease) in trade and other payables 

  Other finance income /(cost) 
Net cash used in operating activities 
Cash flows from investing activities: 

Proceeds from issuance of note receivable  
Repayments of note receivable from subsidiary 

Net cash provided by investing activities 
Cash flows from financing activities: 
     Payments to repurchase ordinary shares 
Net cash used in financing activities 

Net decrease in cash and cash equivalents 
Cash and cash equivalents at beginning of the period 
Cash and cash equivalents at end of the period 

Note 

2022 
$ '000 

2021 
$ '000 

(2,316) 

(38,177) 

3 

3 

(14) 

291 
335 
(92) 
(1,796) 

(716) 
2,598 
1,882 

(245) 
(245) 

(159) 
1,682 
1,523 

250 
36,674 

(23) 
(147) 
19 
(1,404) 

(1,070) 
3,138 
2,068 

(738) 
(738) 

(74) 
1,756 
1,682 

87 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

NOTES TO THE FINANCIAL STATEMENTS 
For the year ended 31 December 2022 

(1) 

Accounting Policies 

Basis of Preparation and Measurement 

The financial statements of the parent company have been prepared under the historical cost convention, 
in accordance with international accounting standards as applied in accordance with the provisions of the 
Companies Act 2006 and in accordance with UK Adopted International Accounting Standards (”IFRS”). A 
summary of the more important accounting policies which have been applied consistently throughout the 
year are set out below. 

Functional and Presentation Currency 

The functional currency of the parent company is British Pounds. The financial statements of the parent 
company are presented in US dollars to the nearest $’000s. 

Foreign Currency 

Transactions  in  foreign  currencies  are  translated  to  the  respective  functional  currencies  of  the  parent 
company at the foreign exchange rate ruling at the date of the transaction. Monetary assets and liabilities 
denominated in foreign currencies at the balance sheet date are retranslated to the functional currency 
at the foreign exchange rate ruling at that date. Foreign exchange differences arising on translation are 
recognised in the income statement. Non-monetary assets and liabilities that are measured in terms of 
historical cost in a foreign currency are translated using the exchange rate at the date of the transaction. 
Non-monetary assets and liabilities denominated in foreign currencies that are stated at fair value are 
retranslated to the functional currency at foreign exchange rates ruling at the dates the fair value was 
determined. 

On translation of the Company financial statements from functional currency to presentational currency 
the  assets  and  liabilities  are  translated  at  the  closing  exchange  rates.  Profit  and  loss  accounts  are 
translated at the average rates of exchange during the year. Gains and losses arising on these translations 
are taken to reserves. Each reporting date, the retained earnings reserve, as measured in the functional 
currency,  is  translated  to  the  presentational  currency  using  the  closing  exchange  rate.  The  retained 
earnings  balance  represents  the  deemed  amount  in  US  Dollars,  measured  at  the  reporting  date, 
equivalent to the functional currency Great British Pounds available for distribution to the shareholders 
from  the  parent  company’s  distributable  reserves.  Any  differences  between  this  amount  and  the 
aggregate of the opening retained earnings measured  at the opening rate and the  profit in the period 
measured at the average rate are recognised in the Translation reserve. 

Intercompany Loans 

All intercompany loans are initially recognised at fair value and subsequently measured at amortised cost. 
Where  intercompany loans  are intended for use on a  continuing  basis in  the  Company’s  activities and 
there  is  no  intention  of  their  settlement  in the  foreseeable  future,  they  are  presented  as  non-current 
assets. 

Cash and Cash Equivalents 

Cash and cash equivalents include all highly liquid instruments with original maturities of three months or 

88 

 
 
FINANCIAL STATEMENTS  

less. 

Impairment 

If there is an indication that an asset might be impaired, the Company will perform an impairment review. 
An asset is impaired if the recoverable amount, being the higher of net realisable value and value in use, 
is less than its carrying amount. Value in use is measured based on future discounted cash flows (“DCF”) 
attributable  to  the  asset.  In  relation  to  the  investment  held  in  subsidiaries  and  intra  group  receivable 
balance the net realisable value is the fair value of the underlying subsidiaries.  In such cases, the carrying 
value of the asset is reduced to recoverable amount with a corresponding charge recognised in the profit 
and loss account.  The underlying assumptions in determining the fair value of the subsidiaries are key 
estimates  and  include  the  determination  of  the  fair  value  as  described  in  note  9  and  14  of  the  group 
financial statements.  

Financial Instruments 

Currently the Company does not enter into derivative financial instruments. Financial assets and financial 
liabilities are recognised and cease to be recognised on the basis of when the related titles pass to or from 
the Company. 

Share-based Payments 

Share-based payment arrangements in which the Company receives goods or services as consideration 
for  its own  equity  instruments  are  accounted  for  as equity-settled  share-based  payment  transactions, 
regardless of  how the  equity instruments are obtained  by the Company.   The Company’s share  based 
payment scheme, which awards shares in the parent entity, includes recipients who are not employees 
the company, but in its subsidiaries.  Where beneficiaries are employees in a subsidiary, their element of 
the share based payment charge would usually be capitalized to recognize the service received by the 
subsidiary.  To  the  extent  that  these  amounts  will  not  be  recovered  the  charge  has  continued  to  be 
expensed by the Company.   

The  grant  date  fair  value  of  share-based  payment  awards  granted  to  employees  is  recognised  as  an 
employee expense, with a corresponding increase in equity, over the period that the employees become 
unconditionally entitled to the awards. The fair value of the options granted is measured using an option 
valuation model, taking into account the terms and conditions upon which the options were granted. The 
amount recognised as an expense is adjusted to reflect the actual number of awards for which the related 
service  and  non-market  vesting  conditions  are  expected  to  be  met,  such  that  the  amount  ultimately 
recognised as an expense is based on the number of awards that do meet the related service and non-
market performance conditions at the vesting date. For share-based payment awards with non-vesting 
conditions, the grant date fair value of the share-based payment is measured to reflect such conditions 
and there is no true-up for differences between expected and actual outcomes. 

(2) 

Cash and Cash Equivalents 

As of 31 December: 

Bank balances 

Cash and cash equivalents 

2022 
$'000 

2021 
$'000 

1,523 
1,523 

1,682 
1,682 

89 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

(3) 

Loan to Subsidiary 

Balance at 1 January 
  Additions 

Impairment 

  Repayments from subsidiaries 

Effect from currency translation 

Balance at 31 December 

2022 
$'000 

2021 
$'000 

 53,271  
 716  
—  
 (2,598) 
 (5,652) 
 45,737  

92,648 
1,070 
(36,674) 
(3,138) 
(635) 
53,271 

The Company has loaned its excess cash to its operating subsidiary Allied Minds, LLC (‘the subsidiary’) , as 
part  of  its  continuing  working  capital  investment  programme  in  the  wider  group,  and  to  be  further 
deployed by the subsidiary, to enable the group to deliver its strategic plans. The note bears an interest 
of 1.25% and in the foreseeable future, repayment is neither planned nor likely to occur.  

During 2022, the Directors reviewed the value of the underlying business and concluded no impairment 
charge should be recorded.  The asset’s recoverable amount is determined to be based on the fair value 
of the company’s subsidiaries together with its associates, preferred shares held and the recoverable cash. 
This has been recorded against the loan to subsidiary balance (this note).  

(4) 

 Share Capital and Reserves 

Allied Minds Plc was incorporated with the Companies House under the Companies Act 2006 as a public 
company on 15 April 2014. Full detail of the share capital and reserves activity for the year can be found 
in note 12 to the consolidated financial statements. 

As of 31 December: 

2022 
$'000 

2021 
$'000 

Equity 
Share capital, $0.01 par value, issued and fully paid 
242,187,985 and 242,187,985, respectively 
Treasury Shares 
Translation reserve 
Accumulated deficit 

Total equity 

3,767 

(983) 
(50,054) 
94,120 

46,850 

3,767 

(738) 
(55,215) 
107,357 

55,171 

In December 2016, the Company issued 17,457,015 ordinary shares of one pence at 367 pence, which 
were admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading 
on the LSE’s Main Market for listed securities. This resulted in approximately $78.1 million of net proceeds 
from the equity placing (net of issue cost of $2.2 million).  The amounts subscribed for share capital in 
excess of the nominal value in relation to this transaction are reflected in the merger reserve balance as 
of 31 December 2016.  

90 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINANCIAL STATEMENTS  

On 17 November 2022, ALM's Board of Directors (the "Board") approved a new share buyback programme 
("Buyback Programme"). The purpose of the buyback programme is to satisfy the Company's obligations 
arising from its 2014 Long Term Incentive Plan ("LTIP"). Following the passing of the Delisting Resolution 
the last day of dealings of the Shares on the Main Market was Tuesday 29 November 2022. Cancellation 
of  the  listing  of  the  Shares  on  the  Official  List  of  the  FCA  took  effect  at  8:00  am  on  Wednesday  30 
November 2022. 

The programme was expected to purchase up to a maximum aggregate consideration of £225,000 of the 
Company's ordinary shares. Share  purchases took  place  in  open market. As of 31 December  2022, the 
Company purchased 2,176,229 of its Ordinary Shares of £0.01 each ("Ordinary Shares") for a total value 
of $245,027. The Ordinary Shares purchased will be held in treasury until transferred by the Company to 
the directors and employees in satisfaction of awards under the 2014 LTIP. 

In  the  period,  management  have  calculated  that  an  amount  of  $10.9  million  foreign  exchange  on 
converting  their functional  currency retained earnings  to the  presentation  currency retained  earnings. 
The cumulative, foreign exchange, amount recorded in retained earnings is $5.7 million.   

(5) 

Directors’ Remuneration, Employee Information and Share-based Payments 

The remuneration of the Directors of the Company is disclosed in note 20 to the consolidated financial 
statements. Full detail of the share-based payment charge and related disclosures can be found in note 6 
to the consolidated financial statements. 

The Company had no employees during 2022 (2021: none). 

91 

 
 
 
 
 
 
Company Information 

Company Registration Number 08998697 

Registered Office  
6th Floor 
65 Gresham Street 
London 
England 
EC2V 7NQ 

Website 
www.alliedminds.com  

Board of Directors  
 Bruce Failing 
(Non-Executive Interim Chairman) 

Sam Dobbyn 
(Non-Executive Director, Audit Committee Chair) 
Juan Morera 
(Non-Executive Director, Remuneration 
Committee Chair) 

Company Secretary 
JTC (UK) Limited 
The Scalpel 
18th Floor 
52 Lime Street 
London 
EC3M 7AF 

Registrar 
Link Group 
The Registry 
Unit 10 
Central Square 
29 Wellington Street 
Leeds 
LS1 4DL 
TEL UK: 0871 664 0300 
TEL Overseas: +44 208 639 3399 

Solicitors 
DLA Piper UK LLP  
160 Aldersgate Street  
London EC1A 4HT  
United Kingdom 
TEL: +44 207 349 0296 

Independent Auditor 
BDO LLP 
55 Baker Street 
London  W1U 7EU 
United Kingdom 
TEL: 020 7486 5888 

92